Page last updated: 2024-11-01

omeprazole and Gastritis

omeprazole has been researched along with Gastritis in 388 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.

Research Excerpts

ExcerptRelevanceReference
" pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone."9.24Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. ( Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY, 2017)
"To date, guidelines on the impact and value of atropine combined with omeprazole in the treatment of acute gastritis have not been well established or well defined."9.12The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis. ( Chen, H; Lin, X; Lin, YN, 2021)
"To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis."9.12Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006)
" pylori) gastritis in children by the adjunction of omeprazole (OAC) was studied."9.12Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. ( Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y, 2007)
" This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)."9.11Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004)
"Both sucralfate and rabeprazole therapies are effective treatment options in the patients with alkaline gastritis when compared with observation."9.10Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. ( Cammarota, G; Candelli, M; Cremonini, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Nista, EC; Santarelli, L, 2003)
"Thirty-eight children with Helicobacter pylori gastritis diagnosed by histopathology, and/or bacteriological culture were treated with omeprazole, amoxicillin and clarithromycin."9.09Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. ( Finkel, Y; Sandstedt, B; Tirén, U, 1999)
"The aim of this multicenter prospective, randomized, double-blind study was to assess the efficacy of the combination of omeprazole, amoxicillin, and clarithromycin (OAC) for the treatment of Helicobacter pylori gastritis in children."9.09Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. ( Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P, 2001)
"Satisfactory antral biopsies were obtained from 119 duodenal ulcer patients before and after 4 wk of therapy with lansoprazole, ranitidine, or placebo."9.08The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. ( Atkinson, BF; Brightman, SA; Jhala, NC; McFarland, MM; Morale, B; Rubin, W, 1995)
"Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers."9.08Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. ( Blum, AL; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B; Verdú, EF, 1996)
" pylori from the gastric mucosa, and omeprazole frequently is used for the treatment of duodenal ulcer disease, prompting the interest to investigate rigorously the combination of clarithromycin and omeprazole for eradicating H."9.08Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. ( Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E, 1996)
"In this randomized multicentre study, 267 duodenal ulcer patients were treated for 2 weeks with omeprazole 40 bid (Group A) or 20 mg bid (Group B), respectively, and with amoxycillin 0."9.08Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. ( Annibale, B; Bordi, C; Cesana, B; Damilano, I; Franceschi, M; Maconi, G; Pilato, FP, 1997)
" pylori and with gastro-oesophageal reflux disease we investigated the gastritis parameters in antral and corpus mucosa before and after 2, 6 and 12 months of treatment with 15 or 30 mg lansoprazole or 20 mg omeprazole/day."9.08Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. ( Alexandridis, T; Meining, A; Schmitz, JM; Seifert, E; Stolte, M, 1998)
" pylori-infected duodenal ulcer patients we investigated the gastritis parameters in antral and corpus mucosa before treatment, after 6 and 12 months of therapy, and 6 months after termination of treatment with 15 mg lansoprazole or 150 mg ranitidine/day."9.08Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. ( Kiel, G; Meining, A; Stolte, M, 1998)
"Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis."9.08Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998)
"Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease."9.07Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994)
"In a controlled, prospective, randomized trial, 10 patients with Helicobacter pylori positive gastritis were treated either with triple therapy (tetracycline, ornidazole, bismuth subcitrate; T, Or, CBS), or omeprazole/CBS (O/CBS) to test the eradication rate of each treatment, its effect on gastritis and meal stimulated gastrin release."9.07[Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study]. ( Bertschinger, P; Brunner, J; Flury, R; Häcki, WH; Jost, R; Lammer, F, 1992)
"This study set out to investigate the effects of omeprazole or ranitidine on the progression of antral gastritis and Helicobacter pylori in patients with active duodenal ulcer."9.07Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. ( Branicki, FJ; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM, 1991)
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia."7.76Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010)
"The present study was designed to investigate the effect of 7,8-dimethoxycoumarin (DMC) isolated from ethyl acetate extract of Citrus decumana peels on gastritis in rats."7.76Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats. ( Bali, M; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S, 2010)
" This study evaluated the inhibitory action of apigenin-7-O-beta-D-glucuronopyranoside (AGC), apigenin, and omeprazole on reflux oesophagitis and gastritis in rats."7.73The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. ( Bai, KL; Choi, HJ; Ham, I; Jeong, JH; Min, YS; Park, SY; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2005)
"To confirm the immediate-type mechanism of recurrent anaphylactic reactions to the repeated administration of omeprazole using skin testing and to enable safe administration of the drug after successful oral desensitization."7.73Anaphylaxis to omeprazole: diagnosis and desensitization protocol. ( Confino-Cohen, R; Goldberg, A, 2006)
"This study evaluated the inhibitory action of luteolin-7-O-beta-D-glucuronopyranoside, luteolin which was isolated from Salix gilgiana leaves, and omeprazole on reflux esophagitis and gastritis in rats."7.73The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats. ( Bai, KL; Ham, I; Kim, JH; Lee, YJ; Min, YS; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2006)
"Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk."7.72Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004)
" pylori infection on gastritis, enterochromaffin-like cell density and hyperplasia, mucosal atrophy and serum gastrin in patients with gastric hypersecretion (basal acid output gt; 15 mmol/h) with either hypergastrinemia (Zollinger-Ellison syndrome) or normal gastrin (non-Zollinger-Ellison syndrome) before and during long-term treatment with lansoprazole."7.71Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. ( Haber, MM; Hirschowitz, BI, 2001)
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6."7.70Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000)
"An antibiotic combination that includes a proton pump inhibitor such as omeprazole and an antibiotic such as clarithromycin is likely to become the new standard regimen for treatment of Helicobacter pylori gastritis because this combination is extremely effective and very well tolerated."7.69Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. ( Getz, HD; Metz, DC, 1995)
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy."7.69Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995)
" The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0."7.69[Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994)
" pylori represents an important factor for the progression of fundic gastritis and the development of argyrophil cell hyperplasia during long-term treatment with lansoprazole."7.69Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. ( Arnold, R; Brunner, G; Eissele, R; Simon, B; Solcia, E, 1997)
"To evaluate the efficacy of one-week therapy with omeprazole, clarithromycin and amoxycillin in eradicating Helicobacter pylori and healing duodenal ulcer."7.69[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. ( Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M, 1997)
"A marked increase in body gastritis was observed in H pylori infected individuals during long term treatment with the proton pump inhibitor lansoprazole."7.69Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. ( Berstad, A; Berstad, AE; Brandtzaeg, P; Hatlebakk, JG; Maartmann-Moe, H, 1997)
"Long-term omeprazole therapy in humans results in moderate hypergastrinemia and a significant argyrophil cell hyperplasia, which are correlated to the grade of corpus gastritis."7.68Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. ( Brunner, G; Creutzfeldt, W; Lamberts, R; Solcia, E; Strüber, HG, 1993)
"Twenty-one patients with endoscopically confirmed duodenal ulceration, who had failed to heal with an H2-antagonist, were given omeprazole 20 mg o."7.68Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. ( Daw, MA; Deegan, P; Leen, E; O'Moráin, C, 1991)
"A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole."7.68Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991)
" HP was eradicated by combined treatment with high-dose omeprazole (2 x 40 mg) and amoxicillin (2 x 1,000 mg; n = 27) administered for 10 days (OME + AMX); alternatively, patients were treated with omeprazole monotherapy (OME) using the same dosage (n = 25)."6.68Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. ( Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Ruckdeschel, G; Sommer, A; Weingart, J, 1995)
"Treatment with omeprazole plus amoxicillin or clarithromycin resulted in encouraging Helicobacter pylori cure rates in pilot and controlled studies."6.68High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. ( Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M, 1995)
" Thus, a true dose-response relationship exists between omeprazole and treatment success."6.68Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. ( Beker, JA; Dekker, CP; Farley, A; Jönsson, A; Klör, HU; Labenz, J, 1997)
"Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output."5.32Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004)
"Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium."5.31[Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000)
"It is used for treatment of gastroduodenal ulcers, reflux oesophagitis and Zollinger Ellison's syndrome."5.29[The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis]. ( Drábek, J; Hanika, J; Soucková, A; Vejvalka, J; Zelenková, J; Zeman, V, 1993)
"Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss."5.29Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996)
"Omeprazole treatment produces lower intragastric pH values 4 weeks after cure of Helicobacter pylori infection than before."5.29Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. ( Armstrong, D; Blum, AL; Börsch, G; Idström, JP; Labenz, J; Stolte, M; Verdú, EF, 1996)
"Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter."5.28Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991)
" pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone."5.24Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. ( Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY, 2017)
" pylori-related chronic gastritis who were randomly provided either 10-day omeprazole-based triple therapy (OM-triple; omeprazole 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1 g twice daily) or 10-day B-quadruple therapy (OM-triple + bismuth subcitrate 120 mg four times daily)."5.24Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China. ( Chen, C; Chen, S; Ding, J; Du, Q; Huang, Z; Jiang, Y; Li, J; Li, W; Lin, Z; Meng, L; Si, J; Wang, L; Wu, L; Ye, B, 2017)
" pylori infection was statistically significantly dependent on omeprazole dosage, CYP2C19 genotype, age, gastritis status, and H."5.15Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. ( Chern, HD; Lin, BR; Lin, CJ; Shun, CT; Wang, HL; Wang, TH; Yang, JC, 2011)
"Ninety-one Helicobacter pylori-positive patients with nonulcer dyspepsia were randomized to receive either lansoprazole, amoxicillin, and clarithromycin or lansoprazole and placebo."5.12Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. ( Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC, 2006)
" Intention-to-treat analysis revealed a trend to a higher healing rate of lymphocytic gastritis 3 months after triple therapy compared with omeprazole/placebo (83."5.12Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. ( Bayerdörffer, E; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neuber, F; Rappel, S; Seitz, G; Stolte, M, 2006)
"To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis."5.12Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006)
" pylori) gastritis in children by the adjunction of omeprazole (OAC) was studied."5.12Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. ( Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y, 2007)
" This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)."5.11Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004)
"Two hundred and forty-three patients received rabeprazole (20 mg or 10 mg) or omeprazole (20 mg) once daily for up to 5 years, for gastro-oesophageal reflux disease and 51% completed the whole 5 year period."5.11Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. ( Fiocca, R; Jacobs, A; Miller, N; Morocutti, A; Rindi, G; Thjodleifsson, B, 2005)
" pylori associated gastritis were randomly divided into pantoprazole triple regimen group (pantoprazole 40 mg, amoxicillin 1 g, and metronidazole 400 mg, bid,for 1-week or 2-weeks) and omeprazole triple regimen (omeprazole 20 mg, amoxicillin 1 g, and metronidazole 400 mg, bid, for 1-week or 2-weeks)."5.10[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. ( Cui, M; Hu, F; Jiang, H; Zheng, X, 2002)
" pylori-positive gastritis or peptic ulcers were randomly assigned to receive 30 mg lansoprazole twice daily (LAC group), 10 mg rabeprazole twice daily (RAC20 group), or 20 mg rabeprazole twice daily (RAC40 group), with 1000 mg amoxicillin twice daily and 400 mg clarithromycin twice daily for 1 week."5.10Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. ( Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM, 2003)
"Both sucralfate and rabeprazole therapies are effective treatment options in the patients with alkaline gastritis when compared with observation."5.10Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. ( Cammarota, G; Candelli, M; Cremonini, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Nista, EC; Santarelli, L, 2003)
"Thirty-eight children with Helicobacter pylori gastritis diagnosed by histopathology, and/or bacteriological culture were treated with omeprazole, amoxicillin and clarithromycin."5.09Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. ( Finkel, Y; Sandstedt, B; Tirén, U, 1999)
" All patients belong to a low socioeconomic strata, had multifocal atrophic gastritis documented by gastric biopsies, and had been treated previously and unsuccessfully for 2 weeks with bismuth subsalicylate (262 mg four times a day), amoxicillin (500 mg three times a day), and metronidazole (400 mg three times a day)."5.09Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. ( Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL, 1999)
" pylori-infected patients with nonulcer dyspepsia to receive twice-daily treatment with 20 mg of omeprazole, 1000 mg of amoxicillin, and 500 mg of clarithromycin for 14 days and 167 such patients to receive identical-appearing placebos; all patients were then followed through regular visits for 12 months."5.09Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. ( Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N, 1999)
" pylori-positive patients who had peptic ulcers or reflux oesophagitis were treated for 3 years with either omeprazole (20 mg/day) alone (n=7) or with omeprazole for primary therapy (8 weeks), followed by famotidine (40 mg/day) for maintenance therapy (n=134)."5.09Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. ( Mashiba, H; Matsumura, N; Okamoto, S; Sasaki, N; Taniyama, K; Uemura, N; Yamaguchi, S; Yamamoto, S, 2000)
"Among the 15 patients with hemorrhagic acute gastritis who were randomly allocated to group A (eradication therapy) or group B (Lansoprazole, LPZ), 10 of them started to receive treatment within 1 day after the disease onset."5.09A short-term eradication therapy for Helicobacter pylori acute gastritis. ( Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T, 2000)
"The aim of this multicenter prospective, randomized, double-blind study was to assess the efficacy of the combination of omeprazole, amoxicillin, and clarithromycin (OAC) for the treatment of Helicobacter pylori gastritis in children."5.09Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. ( Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P, 2001)
"A total of 170 Helicobacter pylori-positive patients with chronic gastritis were randomized to receive one of the following Helicobacter pylori eradication regimens; OAC (omeprazole 20 mg bd, amoxycillin 750 mg bd and clarithromycin 400 mg bd for 1 week) and RAC (rabeprazole 20 mg bd, amoxycillin 750 mg bd and clarithromycin 400 mg bd for 1 week)."5.09Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. ( Azuma, T; Dojo, M; Kuriyama, M; Muramatsu, A; Ohtani, M; Saito, T, 2001)
" Men between 55 and 65 years of age with a gastric cancer phenotype of Helicobacter pylori gastritis are randomized to receive a 7 day course of omeprazole 2 X 20mg, clarithromycin 2 X 500mg, and amoxicillin 2 X 1g for 7 days, or omeprazole 2 X 20mg plus placebo."5.09Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). ( Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M, 2001)
"Satisfactory antral biopsies were obtained from 119 duodenal ulcer patients before and after 4 wk of therapy with lansoprazole, ranitidine, or placebo."5.08The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. ( Atkinson, BF; Brightman, SA; Jhala, NC; McFarland, MM; Morale, B; Rubin, W, 1995)
"pylori positive (histology and/or culture) ulcer disease (n = 17; acute ulcer: n = 11) or functional dyspepsia (n = 13) were treated over one week with pantoprazole 40 mg bd, clarithromycin 250 mg bd and metronidazole 400 mg bd."5.08[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. ( Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B, 1995)
"Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers."5.08Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. ( Blum, AL; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B; Verdú, EF, 1996)
"The combined therapy with amoxycillin, metronidazole, and omeprazole is highly effective in both HP eradication and prevention of duodenal ulcer recurrence."5.08Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. ( Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L, 1996)
"Changes in Helicobacter pylori-associated gastritis of the antrum and corpus were investigated in a large number of patients treated with omeprazole, with or without the addition of amoxycillin."5.08Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics. ( Carlsson, J; Fiocca, R; Rudbäck, A; Solcia, E; Villani, L; Zeijlon, L, 1996)
" pylori infection in patients with chronic gastritis (CG), duodenal ulcer (DU), and gastric ulcer (GU) after two dual therapies (omeprazole with either amoxycillin or clarithromycin)."5.08Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. ( Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C, 1996)
" pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients."5.08Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997)
" pylori-associated gastritis were treated with 20 mg omeprazole once daily in the morning, 20 mg omeprazole b."5.08An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively. ( Bayerdörffer, E; Hele, C; Lehn, N; Mannes, GA; Miehlke, S; Stolte, M, 1997)
"The purpose of the present study was to examine the association between interleukin-8 (IL-8) in the gastric body due to Helicobacter pylori infection and histological gastritis, as well as elucidating the effect of acid secretion inhibitors on H."5.08Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. ( Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Oomoto, Y; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S, 1997)
" pylori-infected patients with endoscopically documented duodenal ulcer either currently or within the past year were randomized to 14 days of (1) lansoprazole, 30 mg bid, plus amoxicillin, 1 gm tid; (2) lansoprazole, 30 mg tid, plus amoxicillin, 1 gm tid; (3) lansoprazole, 30 mg tid alone; or (4) amoxicillin, 1 gm tid alone."5.08Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. ( Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A, 1996)
" pylori from the gastric mucosa, and omeprazole frequently is used for the treatment of duodenal ulcer disease, prompting the interest to investigate rigorously the combination of clarithromycin and omeprazole for eradicating H."5.08Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. ( Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E, 1996)
" Patients (n = 787) with proved duodenal ulcer disease were randomized to treatment twice daily for 1 week with omeprazole, 20 mg (O), plus either placebo (P) or combinations of two of the following antimicrobials: amoxicillin, 1 gm (A), clarithromycin, 250 or 500 mg (C250, C500), or metronidazole, 400 mg (M)."5.08Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. ( Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M, 1996)
"In this randomized multicentre study, 267 duodenal ulcer patients were treated for 2 weeks with omeprazole 40 bid (Group A) or 20 mg bid (Group B), respectively, and with amoxycillin 0."5.08Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. ( Annibale, B; Bordi, C; Cesana, B; Damilano, I; Franceschi, M; Maconi, G; Pilato, FP, 1997)
" pylori and with gastro-oesophageal reflux disease we investigated the gastritis parameters in antral and corpus mucosa before and after 2, 6 and 12 months of treatment with 15 or 30 mg lansoprazole or 20 mg omeprazole/day."5.08Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. ( Alexandridis, T; Meining, A; Schmitz, JM; Seifert, E; Stolte, M, 1998)
" pylori-infected duodenal ulcer patients we investigated the gastritis parameters in antral and corpus mucosa before treatment, after 6 and 12 months of therapy, and 6 months after termination of treatment with 15 mg lansoprazole or 150 mg ranitidine/day."5.08Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. ( Kiel, G; Meining, A; Stolte, M, 1998)
" pylori-associated gastritis, received seven days of lansoprazole, bismuth, tetracycline and metronidazole after three days of lansoprazole pretreatment."5.08Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection. ( Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB, 1998)
"Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis."5.08Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998)
"Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease."5.07Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994)
" pylori infection and gastritis were treated with one of the following four regimens: omeprazole 40 mg/day for one week (group A, n = 14); omeprazole 40 mg/day for one week followed by clarithromycin 1 g/day for 2 weeks (group B, n = 26); omeprazole 40 mg/day for one week followed by tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day, both for two weeks (group C, n = 26); and tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day for two weeks (group D, n = 22)."5.07Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. ( Cuccurullo, F; Di Iorio, P; Laterza, F; Mezzetti, A; Neri, M; Seccia, G; Susi, D, 1994)
"In a controlled, prospective, randomized trial, 10 patients with Helicobacter pylori positive gastritis were treated either with triple therapy (tetracycline, ornidazole, bismuth subcitrate; T, Or, CBS), or omeprazole/CBS (O/CBS) to test the eradication rate of each treatment, its effect on gastritis and meal stimulated gastrin release."5.07[Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study]. ( Bertschinger, P; Brunner, J; Flury, R; Häcki, WH; Jost, R; Lammer, F, 1992)
"In an open study, 62 patients with Helicobacter pylori-associated ulcer disease or functional dyspepsia were treated for two weeks with 2 x 20 mg omeprazole preprandially and 4 x 500 mg amoxicillin suspension one hour before meals and at night."5.07Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori. ( Börsch, G; Gyenes, E; Labenz, J; Rühl, GH, 1992)
" pylori-associated gastritis were allocated to one of the following four therapeutic schedules: 1) omeprazole 40 mg/d for 4 weeks (n = 13); 2) bismuth subsalicylate (BSS) 3 x 600 mg for 4 weeks (n = 12); 3) omeprazole plus BSS for 4 weeks (n = 13); 4) triple therapy (BSS for 4 weeks, amoxicillin 3 x 750 mg and metronidazole 3 x 400 mg for 10 days) (n = 12)."5.07The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection. ( Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S, 1991)
"This study set out to investigate the effects of omeprazole or ranitidine on the progression of antral gastritis and Helicobacter pylori in patients with active duodenal ulcer."5.07Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. ( Branicki, FJ; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM, 1991)
" In the treatment of gastric ulcer, analysis of all studies that have compared lansoprazole, a newly developed proton pump inhibitor, and H2-receptor antagonists has shown a statistically significant difference for a higher healing rate with lansoprazole."4.78Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. ( Florent, C, 1993)
" pylori culture positive dyspeptic patients (64 patients with peptic ulcer, PU) completed a 2-week treatment with omeprazole, amoxicillin and metronidazole and underwent endoscopy again 6-8 weeks after the end of therapy."3.78Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection. ( Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C, 2012)
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia."3.76Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010)
"The present study was designed to investigate the effect of 7,8-dimethoxycoumarin (DMC) isolated from ethyl acetate extract of Citrus decumana peels on gastritis in rats."3.76Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats. ( Bali, M; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S, 2010)
"The authors made an attempt to find a new approach to Helicobacter pylori (HP) eradication in patients with chronic gastritis and peptic ulcer without application of antibiotics, but using melatonin properties instead."3.74[Antihelicobacter effects of melatonin]. ( Malinovskaia, NK; Parkhomenko, IE; Postnikova, LI; Rapoport, SI; Rybnikova, SN; Zhernakova, NI, 2007)
"This is our final report on the clinical effectiveness and safety of long-term pantoprazole in patients with severe peptic ulcer or reflux disease during continuous treatment for up to 5 years."3.73Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. ( Bardhan, KD; Bishop, AE; Luehmann, R; McCaldin, B; Morris, P; Polak, JM; Romanska, HM; Rowland, A; Schaefer-Preuss, S; Thompson, M, 2005)
" This study evaluated the inhibitory action of apigenin-7-O-beta-D-glucuronopyranoside (AGC), apigenin, and omeprazole on reflux oesophagitis and gastritis in rats."3.73The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. ( Bai, KL; Choi, HJ; Ham, I; Jeong, JH; Min, YS; Park, SY; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2005)
" The patient was also treated with omeprazole (20 mg/day) because of chronic gastritis."3.73Gastric pH, sevelamer hydrochloride and omeprazole. ( Capitanini, A; Del Corso, C; Gallieni, M; Lupi, A; Osteri, F; Petrone, I; Rossi, A; Straniti, M, 2005)
"To confirm the immediate-type mechanism of recurrent anaphylactic reactions to the repeated administration of omeprazole using skin testing and to enable safe administration of the drug after successful oral desensitization."3.73Anaphylaxis to omeprazole: diagnosis and desensitization protocol. ( Confino-Cohen, R; Goldberg, A, 2006)
"This study evaluated the inhibitory action of luteolin-7-O-beta-D-glucuronopyranoside, luteolin which was isolated from Salix gilgiana leaves, and omeprazole on reflux esophagitis and gastritis in rats."3.73The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats. ( Bai, KL; Ham, I; Kim, JH; Lee, YJ; Min, YS; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2006)
" pylori infection who had gastritis, duodenal ulcer (DU) or gastric ulcer (GU) received 1 week's triple therapy of lansoprazole 30 g once daily (OD), amoxycillin 250 mg qid and clarithromycin 250 mg tid."3.72Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. ( Uthaisaengsook, W, 2003)
"Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk."3.72Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004)
" The patient underwent 7 days of clarithromycin, amoxicillin, and omeprazole treatment for Helicobacter pylori-associated gastritis."3.72Acute colchicine intoxication during clarithromycin administration. ( Blanche, P; Chauvelot-Moachon, L; Kélaïdi, C; Nazal, EM; Pajot, O; Rollot, F, 2004)
" pylori infection on gastritis, enterochromaffin-like cell density and hyperplasia, mucosal atrophy and serum gastrin in patients with gastric hypersecretion (basal acid output gt; 15 mmol/h) with either hypergastrinemia (Zollinger-Ellison syndrome) or normal gastrin (non-Zollinger-Ellison syndrome) before and during long-term treatment with lansoprazole."3.71Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. ( Haber, MM; Hirschowitz, BI, 2001)
" Therefore, we investigated how the chronic gastritis in mice made hypochlorhydric by either gastrin deficiency or omeprazole treatment modulates epithelial cell function."3.71Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. ( Ferguson, A; Merchant, JL; Rieder, G; Samuelson, LC; Zavros, Y, 2002)
"Thirty-eight clinical strains of Helicobacter pylori were isolated from patients with chronic gastritis and gastroduodenal ulceration, and their susceptibility to macrolide antibiotics (roxithromycin, flurithromycin, azithromycin, erythromycin) in combination with proton-pump inhibitors (lansoprazole and omeprazole) and bismuth subcitrate was assayed."3.70Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. ( Campa, M; Favini, P; Malizia, T; Marchetti, F; Pizzarelli, G; Senesi, S; Tejada, M, 1998)
"Gastric juice pH, ammonia concentration in gastric juice, serum gastrin level, and grade of gastritis in accordance with the Sydney System were determined for patients with gastric ulcer (GU) and duodenal ulcer (DU) before and after treatment with lansoprazole and amoxicillin, and results were compared with those of H."3.70Effect of Helicobacter pylori infection on gastric juice pH. ( Arai, H; Baba, S; Furuta, T; Futami, H; Hanai, H; Kajimura, M; Kaneko, E; Takashima, M, 1998)
" pylori strain (34 duodenal ulcer and 37 nonulcer dyspepsia) received omeprazole 40 mg o."3.70Weekend therapy for the treatment of Helicobacter pylori infection. ( Agosti, R; Bocus, P; Caletti, G; Grigioni, WF; Mazzoni, C; Orcioni, GF; Paparo, GF; Poli, L; Sottili, S; Togliani, T; Tucci, A, 1998)
"One hundred eight patients with cultured H pylori-positive gastritis or peptic ulcer were treated with three regimens: quadruple treatment without proton pump inhibitors (n = 25), dual treatment with omeprazole and amoxicillin (INN, amoxicilline) (n = 26), and triple treatment with omeprazole, amoxicillin, and clarithromycin (n = 57)."3.70CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. ( Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y, 1999)
" pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk."3.70The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000)
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6."3.70Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000)
" Given the histology and the fact that rapid urease test results were positive, chronic active gastritis with H."3.70Iron-deficiency anemia associated with Helicobacter pylori gastritis. ( Imai, T; Konno, M; Muraoka, S; Takahashi, M, 2000)
" pylori lipopolysaccharide-induced acute gastritis to study the effect of antiulcer agents, omeprazole and sucralfate, on the course of mucosal inflammatory responses by analyzing the interplay between the extent of epithelial cell apoptosis and the mucosal expression of endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-alpha), and the activity of constitutive (cNOS) and inducible (NOS-2) nitric oxide synthase."3.70Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate. ( Piotrowski, J; Slomiany, A; Slomiany, BL, 2000)
" pylori with omeprazole and amoxicillin, the skin changes, gastric complaints, and proteinuria disappeared."3.69Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. ( Borchard, F; Goerz, G; Megahed, M; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F, 1995)
" pylori testing in patients on profound acid suppressive therapy should be performed on combined corpus and antral specimens, and 2) that omeprazole therapy leads to a strong increase in corpus gastritis, which may explain the observed development of corpus atrophy in a substantial number of patients after several years of continuous acid suppressive treatment."3.69Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. ( Bloemena, E; Hazenberg, HJ; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Meuwissen, SG; Peña, AS; Uyterlinde, AM, 1995)
"An antibiotic combination that includes a proton pump inhibitor such as omeprazole and an antibiotic such as clarithromycin is likely to become the new standard regimen for treatment of Helicobacter pylori gastritis because this combination is extremely effective and very well tolerated."3.69Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. ( Getz, HD; Metz, DC, 1995)
" 33 patients with primary gastric low-grade MALT lymphoma associated with H pylori gastritis were treated with omeprazole (120 mg daily) and amoxycillin (2."3.69Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. ( Bayerdörffer, E; Eidt, S; Lehn, N; Neubauer, A; Rudolph, B; Stolte, M; Thiede, C, 1995)
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy."3.69Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995)
"These findings indicate that (1) peptic esophagitis was a common cause of chronic abdominal pain in pediatric patients and (2) omeprazole was effective in the treatment of esophagitis in children and adolescents that was resistant to high-dose histamine2-receptor antagonists."3.69Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. ( Kane, R; Karjoo, M, 1995)
" The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0."3.69[Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994)
"Bacterial overgrowth of the small intestine commonly occurs in association with hypochlorhydria caused by atrophic gastritis or during treatment with omeprazole."3.69Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. ( Golner, B; Kowdley, KV; Pedrosa, MC; Perrone, G; Russell, RM; Saltzman, JR; Sepe, T, 1994)
" pylori represents an important factor for the progression of fundic gastritis and the development of argyrophil cell hyperplasia during long-term treatment with lansoprazole."3.69Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. ( Arnold, R; Brunner, G; Eissele, R; Simon, B; Solcia, E, 1997)
"To evaluate the efficacy of one-week therapy with omeprazole, clarithromycin and amoxycillin in eradicating Helicobacter pylori and healing duodenal ulcer."3.69[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. ( Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M, 1997)
"A marked increase in body gastritis was observed in H pylori infected individuals during long term treatment with the proton pump inhibitor lansoprazole."3.69Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. ( Berstad, A; Berstad, AE; Brandtzaeg, P; Hatlebakk, JG; Maartmann-Moe, H, 1997)
" Thirty-two consecutive patients (suffering from either peptic ulcer or nonulcer dyspepsia) with Helicobacter pylori infection received omeprazole (40 mg) + bismuth subcitrate (240 mg x 4) + amoxicillin suspension (2000 mg x 4) + metronidazole (500 mg x 4), for only one day."3.68One-day therapy for treatment of Helicobacter pylori infection. ( Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O, 1993)
"Long-term omeprazole therapy in humans results in moderate hypergastrinemia and a significant argyrophil cell hyperplasia, which are correlated to the grade of corpus gastritis."3.68Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. ( Brunner, G; Creutzfeldt, W; Lamberts, R; Solcia, E; Strüber, HG, 1993)
"Twenty-one patients with endoscopically confirmed duodenal ulceration, who had failed to heal with an H2-antagonist, were given omeprazole 20 mg o."3.68Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. ( Daw, MA; Deegan, P; Leen, E; O'Moráin, C, 1991)
"A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole."3.68Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991)
"Biopsies from the stomachs (antrum and corpus) of 201 patients with peptic ulcers or reflux oesophagitis were retrospectively investigated for the effect of treatment with omeprazole on the elimination of Helicobacter pylori (HP) and on gastritis."3.68Elimination of Helicobacter pylori under treatment with omeprazole. ( Bethke, B; Stolte, M, 1990)
"Gastritis was assessed according to the updated Sydney classification for activity, chronic inflammation, gastric glandular atrophy, intestinal metaplasia, and H."2.74Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. ( Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA, 2009)
"pylori decreases gastric cancer risk, using preneoplastic conditions as surrogate markers."2.71Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Johnstone, I; Ley, C; Mohar, A; Parsonnet, J, 2004)
"Esomeprazole has higher oral bioavailability and increased antimicrobial activity against Helicobacter pylori than omeprazole."2.71Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. ( Anagnostopoulos, GK; Arvanitidis, D; Kostopoulos, P; Margantinis, G; Tsiakos, S, 2004)
" A therapeutical scheme (omeprazole, metronidazole, amoxicilline) obtained a further pathogenetic substantiation of B type CG patient treatment with additional antioxidant vitamin E use at the dosage of 300 mg/day for three weeks."2.71[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis]. ( Postavnyĭ, VE, 2005)
"Helicobacter pylori gastritis is usually a lifelong disease which can cause different topographical inflammatory reactions and induce divergent effects on acid secretion in humans."2.70Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. ( Färkkilä, M; Koskenpato, J; Sipponen, P, 2002)
" We performed serial endoscopy, checked for adverse events, and laboratory values."2.70Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. ( Bardhan, KD; Bishop, AE; Cherian, P; Fischer, R; Lühmann, R; McCaldin, B; Morris, P; Ng, W; Perry, MJ; Polak, JM; Romanska, H; Rowland, A; Schneider, A; Thompson, M, 2001)
" Sixty-eight patients received 30 mg of lansoprazole once daily, 500 mg of amoxicillin and 250 mg of metronidazole thrice daily for 2 weeks (LAM group), while the other 67 patients received the same dosage of those agents plus 18,000 tyrosine units of pronase thrice daily for 2 weeks (LAMP group)."2.70Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. ( Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A, 2002)
"Omeprazole pretreatment did not influence eradication rates."2.69Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study. ( Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD; Victor, L, 1998)
"The 1-week triple therapy was safe and effective for eradicating H."2.69Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. ( Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T, 1998)
"pylori-related gastritis, have focused mainly on medium and long-term change following eradication therapies."2.69Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy. ( Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR, 1999)
"Chronic urticaria is one of the most frequent skin diseases."2.69Helicobacter pylori as a possible bacterial focus of chronic urticaria. ( Brehler, R; Domschke, W; Foerster, E; Luger, TA; Pohle, T; Wustlich, S, 1999)
" The aim of this study was to determine the optimal dose and duration of lansoprazole (LA) administration in combination with amoxicillin (AMPC) and metronidazole (MNZ)."2.69Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy. ( Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J, 1999)
"Metronidazole resistance was found in 44% of pre-treatment cultures of H."2.69Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. ( Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI, 2000)
"We present data on development of GERD from a controlled study of H."2.69Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. ( Befrits, R; Lindberg, G; Odman, B; Sjöstedt, S; Sörngård, H, 2000)
"pylori-positive GERD patients randomly assigned to either an eradication or omeprazole-alone regime."2.69Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. ( Axon, AT; Bardhan, K; Dixon, MF; Moayyedi, P; Peacock, R; Walan, A; Wason, C, 2000)
" HP was eradicated by combined treatment with high-dose omeprazole (2 x 40 mg) and amoxicillin (2 x 1,000 mg; n = 27) administered for 10 days (OME + AMX); alternatively, patients were treated with omeprazole monotherapy (OME) using the same dosage (n = 25)."2.68Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. ( Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Ruckdeschel, G; Sommer, A; Weingart, J, 1995)
"Treatment with omeprazole plus amoxicillin or clarithromycin resulted in encouraging Helicobacter pylori cure rates in pilot and controlled studies."2.68High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. ( Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M, 1995)
"Omeprazole has a strong inhibitory effect on H."2.68Effect of omeprazole on Helicobacter pylori urease activity in vivo. ( Domínguez-Muñoz, JE; Kalhori, N; Malfertheiner, P; Sauerbruch, T; Stoschus, B, 1996)
"In five of 20 patients, MALT lymphomas were finally diagnosed."2.68Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? ( Bayerdörffer, E; Hatz, R; Lehn, N; Müller, S; Neubauer, A; Neubauer, B; Otto, P; Ritter, M; Rudolph, B; Seifert, E; Stolte, M; Thiede, C, 1997)
" Thus, a true dose-response relationship exists between omeprazole and treatment success."2.68Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. ( Beker, JA; Dekker, CP; Farley, A; Jönsson, A; Klör, HU; Labenz, J, 1997)
" Group II (n = 47) treated with the same drug and dosage for 2 weeks."2.68[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. ( Bei, L; Chen, S; Chen, Z, 1996)
" Physiologic factors that may contribute to a poor response to these drugs include the considerable variation in the bioavailability of PPIs, the need to take PPIs with meals, the influence of Helicobacter pylori-associated gastritis, and genetic variation in enzyme capacity, resulting in rapid and slow metabolizers of PPIs."2.42Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. ( Richter, JE, 2003)
" Conversely, several studies have shown that long-term use of proton pump inhibitors is associated with progression and worsening of body gastritis exclusively in Helicobacter pylori-positives."2.40Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors? ( Rauws, EA, 1997)
"argyrophilic gastric carcinoids."2.38Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. ( Rindi, G; Silini, E; Solcia, E; Villani, L, 1993)
"Gastritis is a common inflammation of stomach with multiple pathogenesis."1.72Octreotide-based therapies effectively protect mice from acute and chronic gastritis. ( Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q, 2022)
" Examination of eradication rates according to CAM dosage revealed an eradication rate of 65."1.40Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). ( Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A, 2014)
"In two patients with MALT lymphoma, H."1.33Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. ( Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K, 2005)
"Chronic gastritis was evaluated according to sydney system."1.33[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori]. ( Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A, 2006)
"Omeprazole, 20 mg b."1.32Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. ( el-Zimaity, HM; Graham, DY; Opekun, AR; Osato, MS; Yamaoka, Y, 2003)
"Gastric metaplasia was endoscopically and histologically evaluated before and after eradication of this bacterium."1.32Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. ( Sano, T; Urakami, Y, 2003)
"We report on two patients with schizoaffective disorder who received omeprazole in addition to clozapine because of gastrointestinal complaints."1.32Omeprazole reduces clozapine plasma concentrations. A case report. ( Bergemann, N; Frick, A; Kopitz, J, 2003)
"Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output."1.32Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004)
" pylori-infected mucosa and that inhibited the loss of CAM bioavailability in the acidic environment."1.32Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. ( Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K, 2004)
"Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors."1.31Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002)
"pylori and oesophagitis is mediated by the effect of H."1.31Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease? ( Bianchi Porro, G; Pace, F, 2000)
"Treatment with omeprazole, amoxicillin, and clarithromycin resulted in eradication of the infection in all and in resolution of the clinical symptoms in 15 (80%) of 19 patients who had a follow-up examination."1.31Helicobacter pylori infection in recurrent abdominal pain. ( Braegger, CP; Frank, F; Stallmach, T; Stricker, T, 2000)
"Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium."1.31[Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000)
"When omeprazole-treated mice were treated with antibiotics alone, elevated plasma gastrin levels returned to baseline and D cell numbers returned to resting levels despite persistent hypochlorhydria."1.31Hypergastrinemia in response to gastric inflammation suppresses somatostatin. ( Ferguson, A; Merchant, JL; Rieder, G; Samuelson, LC; Zavros, Y, 2002)
"Chronic gastritis was diagnosed in 63 (77."1.31Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. ( Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S, 2001)
"Lactoferrin (Lf) is an iron-binding glycoprotein present in milk, lacrimae, saliva, and gastroduodenal secretions."1.30Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. ( Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N, 1997)
"More than 90% of gastric MALT lymphomas are diagnosed in patients with chronic, Helicobacter pylori-associated gastritis."1.30Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. ( Alpen, B; Bayerdörffer, E; Ehninger, G; Morgner, A; Neubauer, A; Neubauer, B; Ritter, M; Stolte, M; Thiede, C; Wündisch, T, 1997)
"Lansoprazole was mostly prescribed in patients with reflux oesophagitis (55."1.30A prospective follow-up study of 5669 users of lansoprazole in daily practice. ( Claessens, A; Heerdink, E; Lamers, CB; Leufkens, H; van Eijk, J, 1997)
"Gastritis was scored according to Sydney criteria."1.30Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. ( Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L, 1998)
"The laryngitis was clinically and endoscopically unchanged in ten of the twelve (83."1.30[Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study]. ( Arps, H; Diehl, KL; Draf, W; Jaspersen, D; Kind, M; Weber, R, 1998)
"Pretreatment with omeprazole (30 mg/kg s."1.30Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress. ( Arakawa, T; Higuchi, K; Kobayashi, K; Kuroki, T; Takaishi, O; Yamasaki, K, 1999)
"H."1.29Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy. ( Avunduk, C; Coughlin, B; Hampf, F; Navab, F, 1995)
"It is used for treatment of gastroduodenal ulcers, reflux oesophagitis and Zollinger Ellison's syndrome."1.29[The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis]. ( Drábek, J; Hanika, J; Soucková, A; Vejvalka, J; Zelenková, J; Zeman, V, 1993)
"Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss."1.29Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996)
"Omeprazole treatment produces lower intragastric pH values 4 weeks after cure of Helicobacter pylori infection than before."1.29Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. ( Armstrong, D; Blum, AL; Börsch, G; Idström, JP; Labenz, J; Stolte, M; Verdú, EF, 1996)
"Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter."1.28Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991)
"The omeprazole plasma levels were 611 +/- 323 and 881 +/- 533 ng/ml after 2 and 4 h."1.28Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine. ( Bode, JC; Klotz, U; Sarem-Aslani, A; Treiber, G; Walker, S, 1991)
"2."1.28[Current perspectives in ulcer disease]. ( Beglinger, C, 1990)

Research

Studies (388)

TimeframeStudies, this research(%)All Research%
pre-19904 (1.03)18.7374
1990's190 (48.97)18.2507
2000's161 (41.49)29.6817
2010's28 (7.22)24.3611
2020's5 (1.29)2.80

Authors

AuthorsStudies
Lin, X1
Chen, H1
Lin, YN1
Xu, WF1
Wang, Y1
Huang, H1
Wu, JW1
Che, Y1
Ding, CJ1
Zhang, Q1
Cao, WL1
Cao, LJ1
Kim, SE1
Memon, A1
Kim, BY1
Jeon, H1
Lee, WK1
Kang, SC1
Yu, L1
Li, R1
Liu, W2
Zhou, Y1
Li, Y1
Qin, Y1
Chen, Y1
Xu, Y1
Santos Santamarta, F1
Bonoso Criado, R1
Pérez-Millán, AG1
Tan, B1
Luo, HQ1
Xu, H1
Lv, NH1
Shi, RH1
Luo, HS1
Li, JS1
Ren, JL1
Zou, YY1
Li, YQ1
Ji, F1
Fang, JY1
Qian, JM1
Qin, S1
Huang, K1
Fang, Z1
Yin, J1
Dai, R1
Agudo-Fernández, S1
González Blanco, A1
Salar, A1
Köksal, AS1
Onder, FO1
Torun, S1
Parlak, E1
Sayilir, A1
Tayfur, O1
Yildiz, H1
Ozbalci, GS1
Kayaçetin, E1
Sarkeshikian, SS1
Iranikhah, A1
Ghadir, MR1
Baracho, NC1
Ribeiro, RV1
Pereira, RM1
Irulegui, Rde S1
Lambert, D1
Rouger, C1
Diebold, MD1
Ramaholimihaso, F1
Boulagnon, C1
Nguyen, Y1
Hentzien, M1
Jaussaud, R1
Bani-Sadr, F1
Poirier-Guay, MP1
Bélanger, MC1
Frank, D1
Kawai, T1
Takahashi, S2
Suzuki, H4
Sasaki, H1
Nagahara, A1
Asaoka, D1
Matsuhisa, T1
Masaoaka, T1
Nishizawa, T1
Suzuki, M3
Ito, M2
Kurihara, N1
Omata, F1
Mizuno, S1
Torii, A1
Kawakami, K1
Ohkusa, T1
Tokunaga, K1
Mine, T1
Sakaki, N1
Batgi, H1
Akbal, E1
Koçak, E1
Akyürek, Ö1
Köklü, S1
Dönmez, M1
Güneş, F1
Wang, FY1
Liu, JM1
Luo, HH1
Liu, AH1
Jiang, Y2
John, A1
Al Kaabi, S1
Doiphode, S1
Chandra, P1
Sharma, M2
Babu, R1
Yacoub, R1
Derbala, M1
Kato, K2
Tominaga, K1
Sugimori, S1
Nagami, Y1
Kamata, N1
Yamagami, H1
Tanigawa, T1
Shiba, M1
Watanabe, T1
Fujiwara, Y1
Arakawa, T2
Wang, L1
Lin, Z1
Chen, S2
Li, J1
Chen, C1
Huang, Z1
Ye, B1
Ding, J1
Li, W2
Wu, L1
Meng, L1
Du, Q1
Si, J1
Körber, A1
Dissemond, J1
De Leest, HT1
Steen, KS1
Bloemena, E2
Lems, WF1
Kuipers, EJ3
Van de Laar, MA1
Bijlsma, JW1
Janssen, M1
Houben, HH1
Kostense, PJ1
Boers, M1
Dijkmans, BA1
Bago, J1
Pevec, B1
Tomić, M1
Marusić, M2
Bakula, V1
Bago, P1
Petronilho, F1
Araújo, JH2
Steckert, AV1
Rezin, GT2
Ferreira, GK1
Roesler, R2
Schwartsmann, G2
Dal-Pizzol, F2
Streck, EL2
Esedov, EM1
Magomedéminova, AS1
Koosirirat, C1
Linpisarn, S1
Changsom, D1
Chawansuntati, K1
Wipasa, J1
van Zanten, SV1
Desai, S1
Best, L1
Cooper-Lesins, G1
Malatjalian, D2
Haldane, D1
Peltekian, K1
Kohler, JE1
Blass, AL1
Liu, J1
Tai, K1
Soybel, DI1
Sood, S1
Muthuraman, A1
Gill, NS1
Bali, M1
Sharma, PD1
Zhang, J1
Ye, LP1
Shen, LY1
Petronilho, FC1
Gonçalves, CL1
Daufenbach, JF1
Cardoso, MR1
Yang, JC1
Wang, HL1
Chern, HD1
Shun, CT1
Lin, BR1
Lin, CJ1
Wang, TH1
Buonavolontà, R1
Miele, E1
Russo, D1
Vecchione, R1
Staiano, A1
Kim, JY1
Kim, N1
Park, HK1
Jo, HJ1
Shin, CM1
Lee, SH1
Park, YS1
Hwang, JH1
Kim, JW1
Jeong, SH1
Lee, DH1
Nam, RH1
Kim, JM2
Lee, JH1
Jung, HC1
Song, IS1
Tian, XL1
Zhang, JZ1
Zhou, LY1
Geng, QM1
Han, YJ1
Seyyedmajidi, M1
Falaknazi, K1
Mirsattari, D1
Zojaji, H1
Roshani, M1
Lahmi, F1
Orimi, PG1
Hadizadeh, M1
Zali, M1
Figura, N2
Moretti, E1
Vaglio, L1
Langone, F1
Vernillo, R1
Vindigni, C1
Giordano, N1
Kloesel, B1
Chandan, VS1
Alexander, GL1
Prasad, R1
De Silva, M1
Koskenpato, J1
Färkkilä, M2
Sipponen, P2
Mak, SK2
Loo, CK2
Wong, AM1
Wong, PN2
Lo, KY2
Tong, GM2
Lam, EK2
Wong, AK2
Murakami, K5
Sato, R4
Okimoto, T4
Nasu, M4
Fujioka, T5
Kodama, M4
Kagawa, J1
Sato, S2
Abe, H1
Arita, T2
Hirayama, F1
Takagi, S1
Yokoyama, Y1
Yamamoto, K1
Iwao, E1
Haga, K1
Cui, M1
Hu, F1
Jiang, H1
Zheng, X2
Kawano, S1
Wepner, U1
Graham, DY2
Opekun, AR1
Yamaoka, Y1
Osato, MS1
el-Zimaity, HM2
Miki, I1
Aoyama, N3
Sakai, T1
Shirasaka, D2
Wambura, CM1
Maekawa, S2
Kuroda, K2
Tamura, T2
Kita, T2
Sakaeda, T1
Okumura, K2
Kasuga, M3
Orr, CF1
Rowe, DB1
Urakami, Y1
Sano, T1
Ozgenc, F1
Akman, SA1
Arikan, C1
Alkanat, MB1
Aydogdu, S1
Yagci, RV1
Muela Molinero, A1
Ballesteros del Río, B1
Nistal de Paz, F1
Fernandez Pérez, E1
Aguas, M1
Pons, M1
Barrera, N1
Arboix, A1
Eguileor, B1
Delás, J1
Moazzez, R1
Bartlett, D1
Anggiansah, A1
Kaise, M1
Miwa, J1
Iihara, K1
Suzuki, N1
Oda, Y1
Ohta, Y1
Miyamoto, M2
Haruma, K5
Yoshihara, M3
Sumioka, M2
Kamada, T2
Masuda, H1
Nishisaka, T2
Tanaka, S2
Chayama, K2
Hiyama, T1
Frick, A1
Kopitz, J1
Bergemann, N1
Sapone, A1
Vaira, D2
Trespidi, S1
Perna, F1
Gatta, L2
Tampieri, A1
Ricci, C2
Cantelli-Forti, G1
Miglioli, M3
Biagi, GL1
Paolini, M1
Hage, E1
Hendel, L1
Gustafsen, J1
Hendel, J1
van Zanten, SJ1
Kolesnikow, T1
Leung, V1
O'Rourke, JL1
Lee, A1
Santarelli, L1
Gabrielli, M1
Candelli, M1
Cremonini, F1
Nista, EC1
Cammarota, G1
Gasbarrini, G3
Gasbarrini, A2
Richter, JE1
Uthaisaengsook, W1
Nelis, GF1
Klinkenberg-Knol, EC3
Snel, P2
Goldfain, D1
Kolkman, JJ1
Festen, HP1
Dent, J2
Zeitoun, P1
Havu, N2
Lamm, M1
Walan, A3
Ley, C1
Mohar, A1
Guarner, J1
Herrera-Goepfert, R1
Figueroa, LS1
Halperin, D1
Johnstone, I1
Parsonnet, J1
Furuta, T3
Shirai, N2
Xiao, F1
El-Omar, EM1
Rabkin, CS1
Sugimura, H1
Ishizaki, T2
Ohashi, K2
Gillen, D2
Wirz, AA1
McColl, KE2
Di Mario, F5
Ingegnoli, A1
Dal Bò, N2
Cavestro, GM1
Moussa, AM1
Cavallaro, LG1
Aragona, G1
Iori, V1
Pilotto, A5
Franzè, A1
Rugge, M3
Lane, E1
Lobetti, R1
Burroughs, R1
Asaumi, N1
Niiya, K1
Yoshida, C1
Shibakura, M1
Niiya, M1
Tanimoto, M1
Anagnostopoulos, GK1
Tsiakos, S1
Margantinis, G1
Kostopoulos, P1
Arvanitidis, D1
Tiesmeier, J1
Hinner, H1
Kraus, J1
Schuppert, F1
Oderda, G1
Marinello, D1
Lerro, P2
Kuvidi, M1
de'Angelis, GL1
Ferzetti, A1
Cucchiara, S1
Franco, MT1
Romano, C1
Strisciuglio, P1
Pensabene, L1
Topaloglu, U1
Muftuoglu, T1
Akturk, Z1
Ekinci, H1
Peker, O1
Unalmiser, S1
Masaoka, T1
SuzukiKurabayashi, HK1
Kamiya, AG1
Ishii, H3
Kondo, Y2
Joh, T2
Sasaki, M2
Oshima, T3
Itoh, K2
Tanida, S2
Kataoka, H2
Ohara, H2
Nomura, T1
Itoh, M2
Leung, WK1
Lin, SR1
Ching, JY1
To, KF1
Ng, EK1
Chan, FK1
Lau, JY1
Sung, JJ1
Ozturk, Y1
Buyukgebiz, B1
Ozer, E1
Arslan, N1
Bekem, O1
Hizli, S1
Wambura, C1
Ebara, S1
Watanabe, Y1
Calvet, X1
Montserrat, A1
Güell, M1
Vergara, M1
Gené, E1
Rollot, F1
Pajot, O1
Chauvelot-Moachon, L1
Nazal, EM1
Kélaïdi, C1
Blanche, P1
Farinati, F1
Cardin, R1
Russo, VM1
Busatto, G1
Franco, M1
Falda, A1
Mescoli, C1
Watanabe, K3
Kashimura, K1
Miura, M1
Ootsu, S1
Miyajima, H1
Arkkila, PE1
Seppälä, K2
Kosunen, TU2
Mäkinen, J1
Rautelin, H2
Bardhan, KD5
Bishop, AE2
Polak, JM2
Romanska, HM1
Rowland, A2
Thompson, M2
Morris, P2
Schaefer-Preuss, S1
Luehmann, R1
McCaldin, B2
Mana, F1
Van Laer, W1
Van Laere, W1
Bossuyt, A1
Urbain, D1
Hata, M1
Shiono, M1
Sekino, H1
Furukawa, H1
Sezai, A1
Iida, M1
Yoshitake, I1
Hattori, T1
Wakui, S1
Soeda, M1
Taoka, M1
Negishi, N1
Sezai, Y1
Chang, CC1
Chen, SH1
Lien, GS1
Lee, YJ2
Lou, HY1
Hsieh, CR1
Fang, CL1
Pan, S1
Babic, Z1
Nesanovic, M1
Lucijanic-Mlinac, M1
Stajcar, V1
Rindi, G2
Fiocca, R5
Morocutti, A1
Jacobs, A1
Miller, N1
Thjodleifsson, B1
Park, SH1
Park, DI1
Kim, SH1
Kim, HJ2
Cho, YK1
Sung, IK1
Sohn, CI1
Jeon, WK1
Kim, BI1
Keum, DK1
Hershko, C1
Hoffbrand, AV1
Keret, D1
Souroujon, M1
Maschler, I1
Monselise, Y1
Lahad, A1
Sagehashi, Y1
Sugimoto, M1
Nakamura, A1
Kodaira, M1
Kenmotsu, K1
Nagano, M1
Egashira, T1
Ueda, K1
Yoneyama, M1
Hishida, A1
Min, YS2
Yim, SH2
Bai, KL2
Choi, HJ1
Jeong, JH1
Song, HJ2
Park, SY1
Ham, I2
Whang, WK2
Sohn, UD2
Okiyama, Y1
Matsuzawa, K1
Hidaka, E1
Sano, K1
Akamatsu, T2
Ota, H2
Choi, SM1
Kim, DH1
Oh, TY1
Ahn, BO1
Kwon, JW1
Kim, WB1
El-Matary, W1
Dalzell, M1
Ogasawara, N1
Okada, N1
Sano, H1
Nakao, H1
Sobue, S1
Kim, SS1
Meitner, P1
Konkin, TA1
Cho, YS1
Resnick, MB1
Moss, SF1
Magalhães, AF1
Carvalhaes, A1
Natan-Eisig, J1
Paraíso-Ferraz, JG1
Trevisan, M1
Zaterkaad, S1
Capitanini, A1
Lupi, A1
Osteri, F1
Petrone, I1
Del Corso, C1
Straniti, M1
Gallieni, M1
Rossi, A1
Francavilla, R1
Lionetti, E1
Castellaneta, SP1
Magistà, AM1
Boscarelli, G1
Piscitelli, D1
Amoruso, A1
Di Leo, A1
Miniello, VL1
Francavilla, A1
Cavallo, L1
Ierardi, E1
Mazzoleni, LE1
Sander, GB1
Ott, EA1
Barros, SG1
Francesconi, CF1
Polanczyk, CA1
Wortmann, AC1
Theil, AL1
Fritscher, LG1
Rivero, LF1
Cartell, A1
Edelweiss, MI1
Uchôa, DM1
Prolla, JC1
Chan, AO1
Peng, JZ1
Lam, SK2
Lai, KC1
Yuen, MF1
Cheung, HK1
Kwong, YL1
Rashid, A1
Chan, CK1
Wong, BC1
Confino-Cohen, R1
Goldberg, A1
Madisch, A2
Miehlke, S5
Neuber, F1
Morgner, A2
Kuhlisch, E1
Rappel, S1
Lehn, N5
Bayerdörffer, E10
Seitz, G1
Stolte, M24
Abe, T1
Onoda, N1
Katsuragi, K1
Sawada, T1
Maeda, K1
Mino, A1
Ohira, M1
Ishikawa, T1
Wakasa, K1
Hirakawa, K1
Postavnyĭ, VE1
Perri, F2
Leandro, G4
Franceschi, M6
Centanni, M1
Gargano, L1
Canettieri, G1
Viceconti, N1
Franchi, A1
Delle Fave, G3
Annibale, B4
Kim, JH1
Dietrich, JW1
Boehm, BO1
Kawakami, E1
Machado, RS1
Ogata, SK1
Langner, M1
Fukushima, E1
Carelli, AP1
Bonucci, VC1
Patricio, FR1
Khayat, O1
Kilani, A1
Chedly-Debbiche, A1
Zeddini, A1
Gargouri, D1
Kharrat, J1
Souissi, A1
Ghorbel, AJ1
Ben Ayed, M1
Ben Khelifa, H1
Cadranel, S1
Bontemps, P1
Van Biervliet, S1
Alliet, P1
Lauvau, D1
Vandenhoven, G1
Vandenplas, Y1
Minushkin, ON1
Volodin, DV1
Zverkov, IV1
Ivanova, OI1
Shuleshova, AG1
Burdina, EG1
Malinovskaia, NK1
Rapoport, SI1
Zhernakova, NI1
Rybnikova, SN1
Postnikova, LI1
Parkhomenko, IE1
Serebrova, SIu1
Czerwionka-Szaflarska, M1
Brazowski, J1
Koussoulas, V1
Vassiliou, S1
Spyridaki, E1
Demonakou, M1
Vaki, I1
Barbatzas, C1
Giamarellou, H1
Giamarellos-Bourboulis, EJ1
Miwa, H1
Tomita, T1
Kori, M1
Cohen, S1
Levine, A1
Givony, S1
Sokolovskaia-Ziv, N1
Melzer, E1
Granot, E1
Elseweidy, MM1
Younis, NN1
Amin, RS1
Abdallah, FR1
Fathy, AM1
Yousif, ZA1
Robles-Jara, C1
Robles-Medranda, C1
Moncayo, M1
Landivar, B1
Parrales, J1
Avunduk, C1
Navab, F1
Hampf, F1
Coughlin, B1
Labenz, J14
Peitz, U4
Tillenburg, B3
Köhl, H1
Becker, T2
Börsch, G8
Schepp, W1
Jhala, NC1
McFarland, MM1
Brightman, SA1
Morale, B1
Rubin, W1
Atkinson, BF1
Reinauer, S1
Megahed, M1
Goerz, G1
Ruzicka, T1
Borchard, F2
Susanto, F1
Reinauer, H1
Roberts, SJ1
Bateman, DN1
Blum, AL5
Kreiss, C1
Armstrong, D5
Cahill, RJ1
Xia, H1
Kilgallen, C1
Beattie, S1
Hamilton, H1
O'Morain, C5
Mannes, GA2
Sommer, A1
Höchter, W1
Weingart, J1
Hatz, R2
Ruckdeschel, G1
Dirschedl, P1
Blandizzi, C2
Gherardi, G2
Marveggio, C2
Natale, G2
Carignani, D1
Del Tacca, M1
Yabana, T1
Kobayashi, T1
Sugiyama, T4
Uyterlinde, AM1
Peña, AS1
Hazenberg, HJ1
Lindeman, J1
Meuwissen, SG1
Graham, KS1
Malaty, H1
Genta, RM1
Cole, RA1
al-Assi, MT1
Yousfi, MM1
Neil, GA1
Ozmen, MM1
Johnson, CD1
Choné, L1
Fléjou, JF1
Grignon, Y1
Bigard, MA1
Solcia, E7
Silini, E1
Villani, L5
Metz, DC1
Getz, HD1
Forné, M1
Viver, JM1
Espinós, JC1
Coll, I1
Tresserra, F1
Garau, J1
Park, KN1
Hahm, JS1
Neubauer, A5
Rudolph, B2
Thiede, C3
Eidt, S2
Gisbert, JP3
Boixeda, D4
Alvarez Baleriola, I3
Redondo, C2
De Rafael, L1
Martín de Argila, C3
Hernández Ranz, F1
Sood, A1
Jain, NP1
Chawla, LS1
Kumar, R1
Wagner, S2
Beil, W1
Mai, UE1
Bokemeyer, C1
Meyer, HJ1
Manns, MP1
Trespi, E3
Broglia, F1
Luinetti, O3
Karjoo, M1
Kane, R1
tho Pesch, S1
Müller, W1
Peters, U1
Adamek, RJ2
Szymanski, C1
Pfaffenbach, B1
Opferkuch, W2
Ricken, D1
Wegener, M2
Domian, C1
Bertrams, J1
Florent, C1
Domschke, W2
Goh, KL2
Peh, SC2
Parasakthi, N2
Wong, NW1
Tan, KK1
Lo, YL2
Polonio García, MJ1
Merino Romero, J1
Luque Ruano, A1
Sánchez Sánchez, JE1
Patterson, WK1
Sage, RE1
Keefe, DM1
Neri, M1
Susi, D1
Laterza, F1
Di Iorio, P1
Seccia, G1
Mezzetti, A1
Cuccurullo, F1
Krappweis, J1
Petereit, G1
Schentke, KU1
Kirch, W1
Axon, AT3
O'Connor, HJ1
Boldorini, R1
Perego, M2
Alvisi, C2
Lazzaroni, M2
Bianchi Porro, G4
Freston, JW1
Cellini, L4
Allocati, N3
Di Campli, E3
Dainelli, B2
Saltzman, JR1
Kowdley, KV1
Pedrosa, MC1
Sepe, T1
Golner, B1
Perrone, G1
Russell, RM1
Pallone, F1
Luzza, F1
Marcheggiano, A1
Biancone, L1
Torsoli, A1
Capurso, L1
Imoto, I2
Suzuki, S1
Zelenková, J1
Soucková, A1
Drábek, J1
Hanika, J1
Vejvalka, J1
Zeman, V1
Tucci, A2
Corinaldesi, R2
Stanghellini, V1
Paparo, GF2
Gasperoni, S1
Biasco, G2
Varoli, O1
Ricci-Maccarini, M1
Barbara, L2
Lamberts, R2
Creutzfeldt, W2
Strüber, HG1
Brunner, G2
Khulusi, S1
Badve, S1
Patel, P1
Lloyd, R1
Marrero, JM1
Finlayson, C1
Mendall, MA1
Northfield, TC1
Diehl, HG1
de Boer, WA1
Driessen, WM1
Grassi, SA1
Cassaro, M1
Donisi, PM1
Vianello, F1
Kusstatscher, S1
Salandin, S1
Grasso, GA1
Ferrana, M1
Battaglia, G1
Idström, JP4
Verdú, EF3
Dammann, HG2
Artan, R1
Gelen, T1
Bargiggia, S1
Maconi, G3
Cesana, B2
Carlsson, J1
Rudbäck, A1
Zeijlon, L1
Bazzoli, F1
Masulli, M1
Di Bartolomeo, S1
Stermer, E1
Levy, N1
Murata, I1
Yoshikawa, I1
Kuroda, T1
Tabaru, A1
Miura, T1
Otsuki, M1
Goenka, MK1
Das, K1
Vaiphei, K1
Nijhawan, R1
Kocbhar, R1
Gough, AL1
Long, RG1
Cooper, BT3
Fosters, CS1
Garrett, AD1
Langworthy, CH1
Nagahata, Y1
Kawakita, N1
Azumi, Y1
Numata, N1
Yano, M1
Saitoh, Y1
Stoschus, B1
Domínguez-Muñoz, JE1
Kalhori, N1
Sauerbruch, T1
Malfertheiner, P5
Bohmeyer, J1
Heller, A1
Hartig, C1
Wetenberger-Treumann, M1
Huchzermeyer, H1
Otte, HG1
Stadler, R1
Alder, JD1
Ewing, PJ1
Mitten, MJ1
Oleksijew, A1
Tanaka, SK1
Moreno, JA1
Pajares, JM2
Santander, C1
Carpintero, P1
Hermida, C1
Lara, S1
García Grávalos, R1
Nishizono, A1
Nagai, J1
Tokieda, M1
Kodama, R1
Kubota, T1
Rubin, CE1
Petersen, KU1
Malfertheimer, P1
Moshkowitz, M2
Konikoff, FM1
Peled, Y1
Brill, S2
Hallak, A1
Tiomny, E1
Santo, M1
Bujanover, Y2
Gilat, T1
Soffiati, G2
Scagnelli, M2
Bozzola, L3
Valerio, G3
Lux, G1
Jiménez, I1
Pérez García, JI1
Bock, H1
Mares, A1
Wang, XM1
Taniguchi, Y1
Nishifuku, K1
Kidaira, K1
Sato, K1
Sohara, H1
Kawada, H1
Kimura, K1
Kajiwara, M1
Caselli, M1
Trevisani, L1
Tursi, A1
Sartori, S1
Ruina, M1
Luzzi, I1
Gaudenzi, P1
Alvisi, V1
Dohil, R1
Israel, DM1
Hassall, E1
Eissele, R2
Simon, B1
Arnold, R2
Ritter, M2
Müller, S1
Neubauer, B2
Seifert, E2
Otto, P1
Delpre, G1
Livni, E1
Niv, Y1
Hele, C1
Nakao, K1
Ikemura, N1
Shibata, T1
Takaji, S1
Taguchi, Y1
Misaki, M1
Yamauchi, K1
Yamazaki, N1
Mur, M1
Ceña, G1
Abraira, V1
García Plaza, A2
Marignani, M1
Angeletti, S1
Bordi, C2
Malagnino, F1
Mancino, C1
Kato, S2
Takeyama, J1
Ebina, K1
Naganuma, H1
Götz, JM1
Thio, JL1
Verspaget, HW1
Offerhaus, GJ1
Biemond, I1
Lamers, CB2
Veenendaal, RA1
Vcev, A1
Vuković, D1
Ivandić, A1
Vceva, A1
Dmitrović, B1
Kovacić, D1
Volaric, M1
Paulini, D1
Mićunović, N1
Horvat, D1
Mihaljević, S1
Kim, MJ1
Michener, R1
Triadafilopoulos, G1
Beker, JA1
Dekker, CP1
Farley, A1
Klör, HU2
Jönsson, A1
Hirakawa, T1
Tan, WC1
Hogan, J1
Purkayastha, SK1
Lombard, M1
Krasner, N1
Uemura, N2
Oomoto, Y1
Mukai, T1
Okamoto, S2
Yamaguchi, S2
Mashiba, H2
Taniyama, K2
Sasaki, N2
Sumii, K2
Kajiyama, G2
Alpen, B2
Wündisch, T2
Ehninger, G2
Krishnamurthy, S1
Dayal, Y1
Leufkens, H1
Claessens, A1
Heerdink, E1
van Eijk, J1
Harford, W1
Lanza, F1
Arora, A1
Graham, D1
Haber, M1
Weissfeld, A1
Rose, P1
Siepman, N1
Mégraud, F1
Dettmer, A1
Rambow, A1
von Fritsch, E1
Fraser, AG1
Lind, T1
Veldhuyzen van Zanten, S2
Unge, P2
Spiller, R1
Bradette, M1
Chiba, N1
Wrangstadh, M1
Cederberg, C2
van der Hulst, RW1
Keller, JJ1
Rauws, EA2
Tytgat, GN1
Srinivasan, R1
Minocha, A1
Hunt, RH1
Cockeram, A1
Schep, G1
Sidorov, J1
Matisko, A1
Jewell, D1
Bouaniche, M1
Chassagne, P1
Landrin, I1
Fartoukh, C1
Doucet, J1
Metayer, J1
Bercoff, E1
Misiewicz, JJ1
Harris, AW1
Levi, S1
Kerr, GD1
Dixon, MF2
Langworthy, H1
Piper, D1
Berstad, AE1
Hatlebakk, JG1
Maartmann-Moe, H1
Berstad, A1
Brandtzaeg, P1
Marzio, L2
Angelucci, D1
Grossi, L2
Diodoro, MG1
Dubois, A1
Berg, DE1
Fiala, N1
Heman-Ackah, LM1
Perez-Perez, GI1
Blaser, MJ1
Paramsothy, M1
Azian, M1
Bux, S1
Ong, KK1
Pilato, FP1
Damilano, I1
Berquist, WE1
Lanas Arbeloa, A1
Serrano Aulló, MT1
Carnicer, J1
Meining, A3
Schmitz, JM1
Alexandridis, T1
Malizia, T2
Tejada, M1
Marchetti, F1
Favini, P1
Pizzarelli, G1
Campa, M2
Senesi, S2
Chen, Z1
Bei, L1
Baba, S1
Takashima, M1
Futami, H1
Arai, H1
Kajimura, M1
Hanai, H1
Kaneko, E1
Kader, SA1
Mansour, AM1
Mohran, Z1
el-Taoil, A1
Abdalla, KF1
Poli, L1
Bocus, P1
Togliani, T1
Mazzoni, C1
Orcioni, GF1
Agosti, R1
Grigioni, WF1
Sottili, S1
Caletti, G1
Mori, M1
Sakaguchi, AA1
Miura, S1
Parente, F1
Imbesi, V1
Cucino, C1
Manzionna, G1
Vago, L1
Reif, S1
Ringel, Y1
Arber, N1
Halpern, Z1
Jaspersen, D1
Weber, R1
Diehl, KL1
Kind, M1
Arps, H1
Draf, W1
Verdú, E2
Bercík, P2
Costa, F1
Marchi, S1
Bellini, M1
Maltinti, G1
Tacca, MD1
Ellenrieder, V2
Fensterer, H1
Waurick, M1
Adler, G2
Glasbrenner, B2
Kiel, G1
Korman, MG1
Bolin, TD1
Nicholson, FB1
Engelman, JL1
Adamsson, I2
Nord, CE2
Sjöstedt, S2
Wikström, B1
Seensalu, R1
Stack, WA1
Knifton, A1
Thirlwell, D1
Cockayne, A1
Jenkins, D1
Hawkey, CJ1
Atherton, JC1
Meier, E1
Casswall, TH1
Alfvén, G1
Drapinski, M1
Bergström, M1
Dahlström, KA1
Kirstein, FW2
Epple, HJ2
Bojarski, C2
Victor, L1
Fromm, M2
Riecken, EO2
Schulzke, JD2
Ritsuno, H1
Ohnuma, K1
Iinuma, K1
Asaka, M3
Dattilo, M1
Schultz-Süchting, F1
Stallmach, T2
Braegger, CP2
Tirén, U1
Sandstedt, B1
Finkel, Y1
Grimaz, S1
Damiani, D1
Brosolo, P1
Skert, C1
Geromin, A1
de Pretis, G1
Chen, W1
Shu, D1
Wilson, IR1
Tie, A1
Chadwick, VS1
Wustlich, S1
Brehler, R1
Luger, TA1
Pohle, T1
Foerster, E1
Yamasaki, K1
Takaishi, O1
Higuchi, K1
Kobayashi, K1
Kuroki, T1
Yamamoto, T2
Matsumoto, J1
Shiota, K1
Kitajima, S1
Goto, M1
Imaizumi, M1
Arima, T1
Michetti, P1
Dorta, G1
Wiesel, PH1
Brassart, D1
Herranz, M1
Felley, C1
Porta, N1
Rouvet, M1
Corthésy-Theulaz, I1
Abdul Aal, GM1
Dajani, AI1
Nounou, M1
Awad, S1
Abdul Rasheed, Z1
Gautam, S1
Ukabam, S1
Nayal, S1
Fortunato, A1
Rassu, M1
Meli, S1
Lombardo, L2
Masoero, G1
Della Monica, P1
Pera, A1
Mera, R1
Realpe, JL1
Bravo, LE1
DeLany, JP1
Correa, P1
Ali', A1
Menegatti, M1
Landi, F1
Acciardi, C1
Holton, J1
Dong, Q1
Komoto, K1
Mihara, M1
Chen, X1
Tahara, K1
Kawamura, Y1
Boeck, W1
Richter, C1
Marre, R1
Talley, NJ1
Vakil, N1
Ballard, ED1
Fennerty, MB1
Coyle, WJ1
Sedlack, RE1
Nemec, R1
Peterson, R1
Duntemann, T1
Murphy, M1
Lawson, JM1
Tanigawara, Y1
Shirakawa, K1
Komada, F1
Declich, P1
Ambrosiani, L1
Bellone, S1
Tavani, E1
Feldman, M1
Cryer, B1
Sammer, D1
Lee, E1
Spechler, SJ1
Nishikawa, K1
Ishizuka, J1
Kudo, T1
Komatsu, Y1
Katagiri, M1
Sukegawa, M1
Kagaya, H1
Kudo, M1
Kato, M1
Takeda, H1
Toyota, J1
García Pérez, A1
Valverde de La Osa, J1
Giménez Samper, M1
Alonso García, I1
Dillon, J1
Tildesley, G1
Wyatt, JI1
Gatz, G1
Braun, W1
Boixeda de Miquel, D1
Moreira Vicente, V1
Rollan, A1
Giancaspero, R1
Fuster, F1
Acevedo, C1
Figueroa, C1
Hola, K1
Schulz, M1
Duarte, I1
Fölsch, UR1
Hahn, EG1
von Kleist, DH1
Kirchner, T1
Strobel, S1
Kist, M1
Aydin, A1
Ersöz, G1
Tekesin, O1
Akçiçek, E1
Tuncyürek, M1
Georgopoulos, SD1
Ladas, SD1
Karatapanis, S1
Mentis, A1
Spiliadi, C1
Artikis, V1
Raptis, SA1
Shamaly, H1
Berkowitz, D1
Rosenthal, E1
Naveh, Y1
Nelis, F1
Mitchell, B1
Prichard, P1
Lloyd, D1
Frame, MH1
Romàn, J1
Shashidhar, H1
Peters, J1
Lin, CH1
Rabah, R1
Thomas, R1
Tolia, V1
Markert, M1
Crabtree, JE1
Bisson, S1
Edlund, C1
Jakić-Razumović, J1
Tentor, D1
Kusec, V1
Cuzić, S1
Brkić, T1
Vukobrat-Bijedić, Z1
Lacević, N1
Bratović, I1
Gribajcević, M1
Gogov, B1
Radović, S1
Konno, M1
Muraoka, S1
Takahashi, M1
Imai, T1
Slomiany, BL2
Piotrowski, J2
Slomiany, A2
Pace, F1
Mowat, C1
Williams, C1
Hossack, M1
Gilmour, D1
Carswell, A1
Wirz, A1
Preston, T1
Catalano, F1
Catanzaro, R1
Branciforte, G1
Bentivegna, C1
Cipolla, R1
Brogna, A1
Nuciforo, G1
Yamamoto, S1
Matsumura, N1
Frank, F1
Stricker, T1
Giannini, E1
Romagnoli, P1
Fasoli, A1
Chiarbonello, B1
Malfatti, F1
Botta, F1
Risso, D1
Lantieri, PB1
Savarino, V1
Testa, R1
Cacoub, P1
Sbaï, A1
Costedoat-Chalumeau, N1
Bellanger, J1
Godeau, P1
Piette, JC1
Perrucci, V1
Morra, I1
Gaido, F1
Ansaldi, N1
Hirschowitz, BI1
Haber, MM1
Befrits, R1
Odman, B1
Sörngård, H1
Lindberg, G1
Moayyedi, P1
Wason, C1
Peacock, R1
Bardhan, K1
de Luis, DA1
Cordero, JM1
Caballero, C1
Aller, R1
Cantón, R1
de la Calle, H1
Nomura, H1
Miyake, K1
Kashiwagi, S1
Festa, V1
Clemente, R1
Villani, MR1
Quitadamo, M1
Caruso, N1
Bergoli, ML1
Andriulli, A1
Rathi, P1
Sawant, P1
Gopanpallikar, A1
Carratù, R1
Iuliano, D1
Iovene, MR1
Ferraraccio, F1
Esposito, P1
Russo, MI1
Montella, F1
Abbate, G1
Tufano, MA1
Cherian, P1
Romanska, H1
Perry, MJ1
Schneider, A1
Fischer, R1
Ng, W1
Lühmann, R1
Ohara, T1
Goshi, S1
Taneike, I1
Tamura, Y1
Zhang, HM1
Toyoda, H1
Yamaguchi, M1
Nakamura, S1
Nakamura, T1
Kimura, M1
Mukai, K1
Sawa, H1
Kawamura, K1
Shiku, H1
Ashorn, M1
Ruuska, T1
Mäkipernaa, A1
Cicconi, V1
Carloni, E1
Franceschi, F1
Nocente, R1
Silveri, NG1
Manna, R1
Servidei, S1
Bentivoglio, AR1
Plein, K1
Hotz, J1
Grigor'ev, PIa1
Iakovenko, EP1
Talanova, EV1
Tankovic, J1
Lamarque, D1
Lascols, C1
Soussy, CJ1
Delchier, JC1
Geboes, K1
Dekker, W1
Mulder, CJ1
Nusteling, K1
Vichev, E1
Krŭstev, N1
Krŭstev, D1
Baeva, N1
Kiselova, A1
Ianev, N1
Vieth, M1
Gottrand, F1
Kalach, N1
Spyckerelle, C1
Guimber, D1
Mougenot, JF1
Tounian, P1
Lenaerts, C1
Roquelaure, B1
Lachaux, A1
Morali, A1
Dupont, C1
Maurage, C1
Husson, MO1
Barthélemy, P1
Zavros, Y2
Rieder, G2
Ferguson, A2
Samuelson, LC2
Merchant, JL2
Röbbecke, J1
Dojo, M1
Azuma, T1
Saito, T1
Ohtani, M1
Muramatsu, A1
Kuriyama, M1
Martínez-Chamorro, C1
Martínez, E1
Gil-Fernández, JJ1
Escudero, A1
Acevedo, A1
Fernández-Rañada, JM1
Treiber, G2
Wittig, J1
Ammon, S1
Walker, S2
van Doorn, LJ1
Klotz, U2
Koçkar, C1
Oztürk, M1
Bavbek, N1
Kirsch, C1
Dragosics, B1
Gschwantler, M1
Oberhuber, G1
Antos, D1
Dite, P1
Läuter, J1
Leodolter, A2
Schilling, D1
Messerer, P1
Ott, MG1
Schauwecker, P1
Zober, A1
Riemann, JF1
Zullo, A1
Hassan, C1
Lorenzetti, R1
Morini, S1
Kitahora, T1
Miyazawa, M1
Nagahashi, S1
Suzuki, K1
Yoshinaga, M1
Ohtani, A1
Harada, N1
Fukuda, Y1
Nawata, H1
Baena, JM1
López, C1
Hidalgo, A1
Rams, F1
Jiménez, S1
García, M1
Hernández, MR1
Isomoto, H1
Kohno, S1
Suzuki, T1
Ohara, S1
Noguchi, K1
Sekine, H1
Nagura, H1
Shimosegawa, T1
Gotoh, A1
Shimizu, T1
Shimodaira, K1
Kaneko, T1
Kiyosawa, K1
Ishida, K1
Ikeno, T1
Sugiyama, A1
Kawakami, Y1
Katsuyama, T1
Knippig, C1
Arand, F1
Nilius, M1
Klein, U1
Ozdemir, A1
Mas, MR1
Sahin, S1
Sağlamkaya, U1
Ateşkan, U1
Bertschinger, P1
Brunner, J1
Flury, R1
Lammer, F1
Jost, R1
Häcki, WH1
Gyenes, E3
Rühl, GH2
Sherman, P1
Shames, B1
Loo, V1
Matlow, A1
Drumm, B1
Penner, J1
Vaara, M1
Renkonen, OV1
Tsuneoka, K1
Gail, K1
Mihaljevic, L1
Varrentrapp, M1
Lange, P1
Müller, MJ1
Schorn, T1
Soudah, B1
Bär, W1
Gebel, M1
Daw, MA1
Deegan, P1
Leen, E1
Koop, H1
Stumpf, M1
Stöckmann, F1
Di Girolamo, A1
Jenkins, CC1
DeNovo, RC1
Patton, CS1
Bright, RM1
Rohrbach, BW1
Sarem-Aslani, A1
Bode, JC1
Hui, WM1
Ho, J1
Lai, CL1
Lok, AS1
Ng, MM1
Lau, WY1
Branicki, FJ1
Beglinger, C1
Bethke, B1
Darchis, I1
Colombel, JF1
Janin, A1
Collet, R1
Wallaert, B1
Cortot, A1
Collier, DS1
Crampton, J1
Everett, WG1
di Febo, G1
Gad, A1
Gnarpe, H1
Olsson, J1
Bank, S1

Clinical Trials (15)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047]Phase 2/Phase 3138 participants Interventional2006-01-31Recruiting
Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication[NCT03650543]Phase 4133 participants (Actual)Interventional2012-09-10Completed
the Effect of Daily Use of Proton Pump Inhibitors for One Month on Renal Function[NCT03910647]Phase 2200 participants (Anticipated)Interventional2019-12-31Not yet recruiting
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05802888]Phase 4260 participants (Anticipated)Interventional2023-03-12Recruiting
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.[NCT05431075]Phase 4407 participants (Anticipated)Interventional2022-07-31Not yet recruiting
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05432115]Phase 4407 participants (Anticipated)Interventional2022-06-25Recruiting
European Registry on the Management of Helicobacter Pylori Infection[NCT02328131]10,000 participants (Anticipated)Observational2013-06-30Recruiting
Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori[NCT00149084]Phase 3296 participants Interventional2003-04-30Recruiting
Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441]Phase 4338 participants (Actual)Interventional2010-12-31Completed
Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection[NCT00656968]Phase 4232 participants (Actual)Interventional2007-05-31Completed
Dyspeptic Symptoms Evolution After Eradication of Helicobacter Pylori in Patients With Different Endoscopic Findings: a Randomized Double-blind Placebo-controlled Clinical Trial With 12 Months of Follow-up[NCT00404534]Phase 3407 participants (Actual)Interventional2006-10-31Completed
Treatment of Low-Grade Gastric Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)[NCT00154440]Phase 3200 participants Interventional2001-11-30Recruiting
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757]48 participants (Anticipated)Interventional2012-03-31Not yet recruiting
Effectiveness of Rifabutin Triple Therapy for First-line and Rescue Treatment of Helicobacter Pylori Infection[NCT04652284]Phase 3300 participants (Anticipated)Interventional2021-05-01Not yet recruiting
Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori[NCT05957432]Phase 290 participants (Anticipated)Interventional2023-07-15Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants in Which H. Pylori Was Eradicated

Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT00656968)
Timeframe: one month after finishing study drugs

Interventionparticipants (Number)
Concomitant Therapy (A)92
Sequential Therapy (B)95

Number of Participants Who Had Good Drug Compliance

Good drug compliance is defined as taking equal to or more than 80% of eradication medicines (NCT00656968)
Timeframe: one month after finishing test therapy

Interventionparticipants (Number)
Concomitant Therapy (A)106
Sequential Therapy (B)104

Reviews

26 reviews available for omeprazole and Gastritis

ArticleYear
The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis.
    Annals of palliative medicine, 2021, Volume: 10, Issue:9

    Topics: Atropine; Gastritis; Humans; Omeprazole; Treatment Outcome

2021
Gastric MALT lymphoma and Helicobacter pylori.
    Medicina clinica, 2019, 01-18, Volume: 152, Issue:2

    Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Ther

2019
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2002, Volume: 99, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combinati

2002
Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.
    The American journal of medicine, 2003, Aug-18, Volume: 115 Suppl 3A

    Topics: Age Factors; Barrett Esophagus; Female; Gastric Acid; Gastritis; Gastroesophageal Reflux; Gastrointe

2003
[The treatment of Helicobacter pylori infection in upper gastrointestinal disorders].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Dyspepsia; Gastritis; Gastrointes

2003
[Eradication of Helicobacter pylori].
    Krankenpflege Journal, 2005, Volume: 43, Issue:4-6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy,

2005
[Proton pump inhibitors in developmental period medicine].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2007, Volume: 22, Issue:128

    Topics: Adult; Age Factors; Anti-Ulcer Agents; Child; Drug Interactions; Duodenitis; Enzyme Inhibitors; Esom

2007
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:3

    Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis

1995
[How to use proton pump inhibitors and histamine H2 antagonists in the therapy of peptic ulcer].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Jun-10, Volume: 84, Issue:6

    Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazol

1995
Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
    Bailliere's clinical gastroenterology, 1993, Volume: 7, Issue:1

    Topics: Animals; Carcinoid Tumor; Enterochromaffin Cells; Gastric Acid; Gastric Mucosa; Gastrins; Gastritis;

1993
Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Clinical therapeutics, 1993, Volume: 15 Suppl B

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Gastroesophag

1993
Omeprazole, Helicobacter pylori, and gastritis.
    Journal of gastroenterology, 1994, Volume: 29 Suppl 7

    Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicoba

1994
[Omeprazole treatment and fever].
    Medicina clinica, 1994, Sep-24, Volume: 103, Issue:9

    Topics: Aged; Aged, 80 and over; Fever; Gastritis; Hernia, Hiatal; Humans; Male; Omeprazole

1994
The role of acid inhibition in the treatment of Helicobacter pylori infection.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 201

    Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric

1994
The role of Helicobacter pylori in peptic ulcer disease.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 201

    Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helic

1994
Emerging strategies for managing peptic ulcer disease.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 201

    Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Depression, Chemical; Drug Therapy, Combinatio

1994
[Current therapy of Helicobacter pylori infection].
    Leber, Magen, Darm, 1994, Volume: 24, Issue:1

    Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infe

1994
[Diagnosis and treatment of Helicobacter pylori].
    Nihon Ika Daigaku zasshi, 1997, Volume: 64, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Dr

1997
Treatment of Helicobacter pylori infection: a review of the world literature.
    Helicobacter, 1996, Volume: 1, Issue:1

    Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Micro

1996
Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:6

    Topics: Anti-Ulcer Agents; Atrophy; Gastric Acid; Gastric Mucosa; Gastritis; Gastroesophageal Reflux; Helico

1997
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Gastroenterologia y hepatologia, 1998, Volume: 21 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials a

1998
Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Journal of clinical gastroenterology, 1998, Volume: 27 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; C

1998
[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Revista clinica espanola, 1999, Volume: 199, Issue:11

    Topics: Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Esophageal Diseases; Esophagitis; Gastritis;

1999
Microbial ecology and treatment of Helicobacter pylori infections: review.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin;

2000
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclospo

2002
[Helicobacter heilmannii-associated gastritis].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combina

2002

Trials

144 trials available for omeprazole and Gastritis

ArticleYear
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
    PloS one, 2017, Volume: 12, Issue:4

    Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicob

2017
Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance.
    Acta gastro-enterologica Belgica, 2013, Volume: 76, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Female; Gastritis; Heli

2013
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013, Volume: 24, Issue:1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Drug The

2013
Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:6

    Topics: Adult; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobact

2017
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:2

    Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents

2009
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
    Wiener klinische Wochenschrift, 2009, Volume: 121, Issue:1-2

    Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Sc

2009
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
    International immunopharmacology, 2010, Volume: 10, Issue:7

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load;

2010
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Pharmacotherapy, 2011, Volume: 31, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; C

2011
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
    The Journal of pediatrics, 2011, Volume: 159, Issue:1

    Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; C

2011
Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2011, Volume: 12, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Creatinine; Dose-Response

2011
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:7

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug T

2002
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent

2002
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
    Zhonghua yi xue za zhi, 2002, Sep-25, Volume: 82, Issue:18

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti

2002
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

2003
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.
    Digestive diseases and sciences, 2003, Volume: 48, Issue:4

    Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; E

2003
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Analysis of Variance; Anti-Ulcer Agents; Benzi

2003
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
    Gut, 2004, Volume: 53, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Disease Progression; Double-

2004
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastritis; Helicobacter Infec

2004
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective A

2004
Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study.
    Journal of clinical gastroenterology, 2004, Volume: 38, Issue:6

    Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Esomeprazole; Female; Follow-Up Stud

2004
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Helicobacter, 2004, Volume: 9, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind

2004
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis;

2004
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Gut, 2004, Volume: 53, Issue:9

    Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu

2004
Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:11 Pt 1

    Topics: Anti-Ulcer Agents; DNA Adducts; DNA Damage; Esophageal Diseases; Esophagogastric Junction; Female; G

2004
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent

2005
Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.
    Circulation journal : official journal of the Japanese Circulation Society, 2005, Volume: 69, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedu

2005
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    World journal of gastroenterology, 2005, Apr-21, Volume: 11, Issue:15

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles;

2005
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Dis

2005
Effect of high-dose aspirin on Helicobacter pylori eradication.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromyc

2005
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Gastroenterology, 2005, Volume: 129, Issue:5

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal

2005
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Gastroenterology, 2005, Volume: 129, Issue:5

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal

2005
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Gastroenterology, 2005, Volume: 129, Issue:5

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal

2005
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Gastroenterology, 2005, Volume: 129, Issue:5

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal

2005
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents

2006
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
    Gut, 2006, Volume: 55, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; D

2006
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
    Alimentary pharmacology & therapeutics, 2006, Feb-15, Volume: 23, Issue:4

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Co

2006
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:1 Pt 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benz

2006
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
    Likars'ka sprava, 2005, Issue:8

    Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants;

2005
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Gerontology, 2006, Volume: 52, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents

2006
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.
    The New England journal of medicine, 2006, Apr-27, Volume: 354, Issue:17

    Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Gastric Acid; Gastritis; Goiter; Helicobacter Infec

2006
Furazolidone-based triple therapy for H pylori gastritis in children.
    World journal of gastroenterology, 2006, Sep-14, Volume: 12, Issue:34

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool

2006
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
    Acta paediatrica (Oslo, Norway : 1992), 2007, Volume: 96, Issue:1

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Presc

2007
[Age and eradication treatment of duodenal ulcer].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Combinations;

2007
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
    World journal of gastroenterology, 2007, Sep-14, Volume: 13, Issue:34

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin;

2007
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Co

2008
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?
    World journal of gastroenterology, 2008, May-14, Volume: 14, Issue:18

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dose-Response

2008
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female;

1995
The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-B

1995
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid

1995
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Clarithromyc

1995
Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin.
    Digestion, 1995, Volume: 56, Issue:3

    Topics: Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow

1995
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:9

    Topics: Adult; Amoxicillin; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric

1995
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
    The American journal of gastroenterology, 1995, Volume: 90, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinatio

1995
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:5

    Topics: Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Hel

1995
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    European journal of gastroenterology & hepatology, 1994, Volume: 6 Suppl 1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com

1994
Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.
    Scandinavian journal of gastroenterology, 1994, Volume: 29, Issue:10

    Topics: Adult; Age Factors; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gast

1994
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
    Deutsche medizinische Wochenschrift (1946), 1995, Mar-17, Volume: 120, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom

1995
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
    Digestion, 1995, Volume: 56, Issue:1

    Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer

1995
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:10

    Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies;

1994
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:4

    Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Female; Gastritis; Helicobacter

1994
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 201

    Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastrit

1994
Lansoprazole and Helicobacter pylori infection.
    Clinical therapeutics, 1993, Volume: 15 Suppl B

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method;

1993
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
    Gastroenterology, 1996, Volume: 110, Issue:2

    Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Du

1996
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
    Gastroenterology, 1996, Volume: 110, Issue:3

    Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastric Acidity Determination;

1996
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com

1996
Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics.
    Scandinavian journal of gastroenterology. Supplement, 1996, Volume: 215

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Co

1996
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1996, Volume: 15, Issue:1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ul

1996
Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Diarrhea; Double-Blind Method; Enzyme Inhibitors; Esophagit

1996
Effect of omeprazole on Helicobacter pylori urease activity in vivo.
    European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:8

    Topics: Adult; Aged; Enzyme Inhibitors; Female; Gastritis; Helicobacter pylori; Humans; Male; Middle Aged; O

1996
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Journal of gastroenterology, 1996, Volume: 31 Suppl 9

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Dr

1996
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin

1996
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer

1996
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A

1997
Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cross-Over Studies; Diagnosis, Diffe

1997
An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastriti

1997
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
    Pediatrics, 1997, Volume: 100, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; C

1997
Another therapeutic schedule in eradication of Helicobacter pylori.
    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 1997, Volume: 51, Issue:2

    Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti

1997
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Fema

1997
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
    International journal of clinical practice, 1997, Volume: 51, Issue:4

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination;

1997
Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:4

    Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter I

1997
Parietal cell protrusions in gastric ulcer disease.
    Human pathology, 1997, Volume: 28, Issue:10

    Topics: Chronic Disease; Double-Blind Method; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helico

1997
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
    Helicobacter, 1996, Volume: 1, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diar

1996
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
    Helicobacter, 1996, Volume: 1, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug The

1996
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
    Helicobacter, 1996, Volume: 1, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; D

1996
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:1

    Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; C

1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
    Gut, 1997, Volume: 41, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Age

1997
Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study.
    Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship

1997
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double

1998
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
    Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:12

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug

1996
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
    Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsi

1998
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
    Pediatrics, 1998, Volume: 102, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administrat

1998
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti

1998
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gas

1998
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
    Helicobacter, 1998, Volume: 3, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti

1998
The value of different detection methods of Helicobacter pylori during treatment.
    Journal of clinical gastroenterology, 1998, Volume: 27, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteriological Techniques; Biopsy; Drug Administration

1998
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromy

1998
Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response

1998
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
    Helicobacter, 1998, Volume: 3, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

1998
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole.
    Acta paediatrica (Oslo, Norway : 1992), 1999, Volume: 88, Issue:2

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithr

1999
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Ga

1999
Helicobacter pylori as a possible bacterial focus of chronic urticaria.
    Dermatology (Basel, Switzerland), 1999, Volume: 198, Issue:2

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Female; Gastritis

1999
Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans.
    Digestion, 1999, Volume: 60, Issue:3

    Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bacterial Adhesion; Breath Tests; Colony Count, Micr

1999
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
    Digestion, 1999, Volume: 60, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Cla

1999
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial

1999
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association.
    Italian journal of gastroenterology and hepatology, 1999, Volume: 31, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Do

1999
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
    Journal of clinical gastroenterology, 1999, Volume: 29, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; C

1999
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
    Zeitschrift fur Gastroenterologie, 1999, Volume: 37, Issue:7

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Et

1999
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.
    Helicobacter, 1999, Volume: 4, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinat

1999
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial

1999
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    The New England journal of medicine, 1999, Oct-07, Volume: 341, Issue:15

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Cla

1999
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
    The American journal of physiology, 1999, Volume: 277, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent

1999
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
    Journal of gastroenterology, 1999, Volume: 34 Suppl 11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

1999
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidaz

2000
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
    Helicobacter, 2000, Volume: 5, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul

2000
Garlic oil and Helicobacter pylori infection.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:2

    Topics: Adult; Allyl Compounds; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Disulfides; Dyspe

2000
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 30, Issue:2

    Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool

2000
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 30, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biop

2000
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Zeitschrift fur Gastroenterologie, 2000, Volume: 38, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-

2000
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
    Medicinski arhiv, 2000, Volume: 54, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent

2000
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
    Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

2000
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10

    Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Famotidine; Gastric Mucosa; Gastritis; Gastroscopy; Helicobact

2000
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles

2000
Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease.
    Helicobacter, 2000, Volume: 5, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, C

2000
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
    Helicobacter, 2000, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dr

2000
A short-term eradication therapy for Helicobacter pylori acute gastritis.
    Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Ant

2000
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidaz

2001
Comparison of two regimens on eradication of Helicobacter pylori.
    The Journal of the Association of Physicians of India, 2000, Volume: 48, Issue:8

    Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Th

2000
Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles;

2001
Helicobacter pylori and iron deficiency anaemia in children.
    Scandinavian journal of gastroenterology, 2001, Volume: 36, Issue:7

    Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath T

2001
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Administration Schedule; Endoscopy; Enzyme Inhib

2001
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
    The Journal of pediatrics, 2001, Volume: 139, Issue:5

    Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method;

2001
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastr

2001
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimid

2001
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Archives of internal medicine, 2002, Jan-28, Volume: 162, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

2002
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
    Acta medica (Hradec Kralove), 2001, Volume: 44, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent

2001
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
    World journal of gastroenterology, 2001, Volume: 7, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointe

2001
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Biopsy;

2002
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:3

    Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin

2002
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
    Helicobacter, 2002, Volume: 7, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents

2002
[Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study].
    Schweizerische medizinische Wochenschrift, 1992, Sep-26, Volume: 122, Issue:39

    Topics: Antacids; Breath Tests; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helic

1992
Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
    Zeitschrift fur Gastroenterologie, 1992, Volume: 30, Issue:11

    Topics: Amoxicillin; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, C

1992
[Short-term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication. A pilot study].
    Medizinische Klinik (Munich, Germany : 1983), 1992, Mar-15, Volume: 87, Issue:3

    Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combinati

1992
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
    Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:11

    Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; F

1991
Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment.
    FEMS microbiology letters, 1991, Dec-01, Volume: 68, Issue:3

    Topics: Drug Combinations; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans;

1991
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori.
    Digestive diseases and sciences, 1991, Volume: 36, Issue:5

    Topics: Adult; Chronic Disease; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helicobacter Infecti

1991
Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.
    Scandinavian journal of gastroenterology. Supplement, 1989, Volume: 167

    Topics: Adult; Amoxicillin; Campylobacter Infections; Double-Blind Method; Drug Therapy, Combination; Female

1989

Other Studies

218 other studies available for omeprazole and Gastritis

ArticleYear
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
    European journal of pharmacology, 2022, Aug-05, Volume: 928

    Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infec

2022
Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection.
    Scientific reports, 2020, 06-12, Volume: 10, Issue:1

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial P

2020
Protective Effects of Wheat Peptides against Ethanol-Induced Gastric Mucosal Lesions in Rats: Vasodilation and Anti-Inflammation.
    Nutrients, 2020, Aug-07, Volume: 12, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dinoprostone; Disease Models, Animal; Endothelin-1; Et

2020
Luetic gastritis: an uncommon cause of gastritis.
    Revista espanola de enfermedades digestivas, 2020, Volume: 112, Issue:10

    Topics: Abdominal Pain; Adult; Gastritis; Humans; Nausea; Omeprazole; Vomiting

2020
The effect of Astragaloside IV on ethanol-induced gastric mucosal injury in rats: Involvement of inflammation.
    International immunopharmacology, 2017, Volume: 52

    Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Ethanol; Gast

2017
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera
    Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:8

    Topics: Adult; Aged; Breath Tests; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Fema

2018
Effects of the administration of aqueous extract of de Sedum dendroideum on the histopathology of erosive induced gastritis by means of indomethacin in rats.
    Acta cirurgica brasileira, 2014, Volume: 29, Issue:1

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Gastric Mucosa; Gastritis; Ind

2014
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
    Medecine et maladies infectieuses, 2014, Volume: 44, Issue:7

    Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Dis

2014
Star gazing in a dog: atypical manifestation of upper gastrointestinal disease.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2014, Volume: 55, Issue:11

    Topics: Animals; Diagnosis, Differential; Dog Diseases; Dogs; Female; Gastritis; Omeprazole; Stereotyped Beh

2014
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Journal of gastroenterology and hepatology, 2014, Volume: 29 Suppl 4

    Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter I

2014
Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models.
    Wiener klinische Wochenschrift, 2016, Volume: 128, Issue:Suppl 8

    Topics: Animals; Anti-Ulcer Agents; Gastritis; Gastrointestinal Hemorrhage; Hemostatics; Male; Omeprazole; P

2016
Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice.
    World journal of gastroenterology, 2015, Jul-21, Volume: 21, Issue:27

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Catalase; Clostridium butyricum; Cold Temperature; Disease Mo

2015
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2015, Volume: 34, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combin

2015
Successful Treatment of Early-Diagnosed Primary Phlegmonous Gastritis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:22

    Topics: Anti-Bacterial Agents; Cellulitis; Endoscopy, Digestive System; Gastritis; Humans; Male; Meropenem;

2015
[Palpable purpura with severe pruritus].
    MMW Fortschritte der Medizin, 2008, Apr-24, Volume: 150, Issue:17

    Topics: Aged; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastr

2008
Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
    Peptides, 2009, Volume: 30, Issue:8

    Topics: Animals; Bombesin; Disease Models, Animal; Gastric Mucosa; Gastritis; Indomethacin; Lipid Peroxidati

2009
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
    Klinicheskaia meditsina, 2009, Volume: 87, Issue:7

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Comb

2009
Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2010, Volume: 24, Issue:5

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Dose-Response Relationship, Drug; Drug Admi

2010
Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.
    Free radical biology & medicine, 2010, Sep-01, Volume: 49, Issue:5

    Topics: Ammonium Chloride; Animals; Anti-Ulcer Agents; Antioxidants; Cell Death; Cells, Cultured; Communicab

2010
Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats.
    Journal of Asian natural products research, 2010, Volume: 12, Issue:7

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Citrus; Coumari

2010
Iatrogenic gastric wall abscess infected with Enterobacter cloacae after biopsy.
    Gastrointestinal endoscopy, 2010, Volume: 72, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Comb

2010
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
    Basic & clinical pharmacology & toxicology, 2011, Volume: 108, Issue:3

    Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug

2011
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 58, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Di

2011
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
    Zhonghua nei ke za zhi, 2011, Volume: 50, Issue:7

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobac

2011
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial P

2012
An unusual referral for epigastric pain, nausea, abdominal bloating, diarrhea, and weight loss.
    Gastroenterology, 2012, Volume: 143, Issue:6

    Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Biopsy; Celiac Disease; Diarrhea; Diet, Gluten-Free; Duode

2012
Osteoporosis with underlying connective tissue disease: an unusual case.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant

2002
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat

2002
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
    Journal of gastroenterology, 2002, Volume: 37, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Cla

2002
[A case for proton pump blocker... When cough comes from the stomach].
    MMW Fortschritte der Medizin, 2002, Nov-07, Volume: 144, Issue:45

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age

2002
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; M

2003
Helicobacter pylori hiccup.
    Internal medicine journal, 2003, Volume: 33, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinat

2003
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
    The journal of medical investigation : JMI, 2003, Volume: 50, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug The

2003
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in Turkish children.
    Journal of pediatric gastroenterology and nutrition, 2003, Volume: 36, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Gastritis; Helicobacter Infections; Heli

2003
[Inmediate antphylactic shock after the administration of intravenous omeprazol].
    Revista clinica espanola, 2003, Volume: 203, Issue:4

    Topics: Aged; Anaphylaxis; Anti-Ulcer Agents; Female; Gastritis; Heart Arrest; Humans; Injections, Intraveno

2003
Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.
    Revista espanola de enfermedades digestivas, 2002, Volume: 94, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Follow-Up Studies; Gastric Mucosa; Gastr

2002
Complications of medical management of dental erosion.
    Dental update, 2003, Volume: 30, Issue:2

    Topics: Adult; Enzyme Inhibitors; Gastritis; Gastroesophageal Reflux; Humans; Male; Omeprazole; Proton Pump

2003
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
    Journal of gastroenterology, 2003, Volume: 38, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar

2003
Nodular gastritis in adults is caused by Helicobacter pylori infection.
    Digestive diseases and sciences, 2003, Volume: 48, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy, Needle; Case-Control Studies; Cohort Studies

2003
Omeprazole reduces clozapine plasma concentrations. A case report.
    Pharmacopsychiatry, 2003, Volume: 36, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP1A2; Drug Antagonism; Esophagitis; Femal

2003
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:5

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; C

2003
Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:7

    Topics: Achlorhydria; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cell Division; Drug Administration Schedul

2003
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim

2003
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2003, Volume: 86, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Com

2003
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Singapore medical journal, 2003, Volume: 44, Issue:2

    Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endosco

2003
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.
    Gastroenterology, 2004, Volume: 126, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Fasting; Female; Gastric Acid; Gastric Mucosa; Gast

2004
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?
    Helicobacter, 2004, Volume: 9, Issue:1

    Topics: Abdominal Pain; Anti-Ulcer Agents; Dyspepsia; Gastritis; Gastroesophageal Reflux; Helicobacter Infec

2004
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2004, Volume: 35, Issue:1

    Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination;

2004
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; D

2004
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
    Deutsche medizinische Wochenschrift (1946), 2004, Jul-09, Volume: 129, Issue:28-29

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U

2004
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
    Surgery today, 2004, Volume: 34, Issue:8

    Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydroge

2004
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Mic

2004
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
    Journal of pediatric gastroenterology and nutrition, 2004, Volume: 39, Issue:3

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combi

2004
Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Cyclooxygenase 2; Female; Follow-Up Studies; G

2004
Acute colchicine intoxication during clarithromycin administration.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colchicine; Drug Intera

2004
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age

2004
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count;

2005
The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Breath Tests; Carbon Isotopes; Enzyme Inhibitors; Fem

2005
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
    World journal of gastroenterology, 2005, Feb-21, Volume: 11, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age

2005
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
    Haematologica, 2005, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies

2005
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents

2005
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents

2005
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents

2005
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2005, Volume: 3, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents

2005
The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.
    Autonomic & autacoid pharmacology, 2005, Volume: 25, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apigenin; Clerodendrum; Dose-Re

2005
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
    Pathology international, 2005, Volume: 55, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithrom

2005
Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:7

    Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Arte

2005
Omeprazole-induced hepatitis.
    Pediatric emergency care, 2005, Volume: 21, Issue:8

    Topics: Adolescent; Anti-Ulcer Agents; Chemical and Drug Induced Liver Injury; Female; Gastritis; Humans; Om

2005
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin;

2005
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2006, Volume: 19, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

2006
CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Gastroenterologia y hepatologia, 2005, Volume: 28, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents

2005
Gastric pH, sevelamer hydrochloride and omeprazole.
    Clinical nephrology, 2005, Volume: 64, Issue:4

    Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Interactions; Fema

2005
Anaphylaxis to omeprazole: diagnosis and desensitization protocol.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 96, Issue:1

    Topics: Adult; Anaphylaxis; Desensitization, Immunologic; Enzyme Inhibitors; Gastritis; Helicobacter Infecti

2006
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
    Journal of experimental & clinical cancer research : CR, 2005, Volume: 24, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer

2005
The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats.
    Archives of pharmacal research, 2006, Volume: 29, Issue:6

    Topics: Animals; Antioxidants; Dose-Response Relationship, Drug; Esophagitis, Peptic; Gastric Acid; Gastric

2006
Thyroxine in goiter, H. pylori infection, and gastritis.
    The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adsorption; Anti-Ulcer Agents; Benzimidazoles; Biological A

2006
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
    La Tunisie medicale, 2006, Volume: 84, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; D

2006
[Antihelicobacter effects of melatonin].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:3

    Topics: Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter

2007
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Aci

2007
[Evidence based treatment strategy for dyspeptic symptoms].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:11

    Topics: Dyspepsia; Evidence-Based Medicine; Gastritis; Histamine H2 Antagonists; Humans; Omeprazole; Proton

2007
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 45, Issue:5

    Topics: Abdominal Pain; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Biopsy; Child; Collagen; Collagen Diseas

2007
Effect of some natural products either alone or in combination on gastritis induced in experimental rats.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:7

    Topics: Administration, Oral; Analysis of Variance; Animals; Curcuma; Disease Models, Animal; Fatty Acids, O

2008
Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:11

    Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helico

1995
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
    Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin

1995
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection.
    Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:5 Pt 2

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combinat

1995
Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
    Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Age Distribution; Aged; Antacids; Child; Child, Preschool; Drug Prescriptions; Dr

1995
Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats.
    Digestion, 1995, Volume: 56, Issue:3

    Topics: Animals; Ethanol; Gastric Acid; Gastric Mucosa; Gastritis; Hydrochloric Acid; Male; Misoprostol; Muc

1995
[Progress on therapy of peptic ulcer (discussion)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Jun-10, Volume: 84, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Gastritis; Helicobacter Infections; Helicobacter pylori; Hi

1995
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:9

    Topics: Antacids; Biopsy; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Gastritis, Atrophi

1995
[Therapy of Helicobacter pylori associated diseases].
    Bildgebung = Imaging, 1995, Volume: 62 Suppl 1

    Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combinati

1995
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
    Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy

1995
Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:4

    Topics: Adult; Carbamazepine; Clarithromycin; Drug Interactions; Gastritis; Helicobacter Infections; Helicob

1995
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
    Lancet (London, England), 1995, Jun-24, Volume: 345, Issue:8965

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Female; Follow-Up Studies; Gastritis; Helicobacter Infe

1995
[Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Revista espanola de enfermedades digestivas, 1995, Volume: 87, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Female; Follo

1995
Esophageal candidiasis following omeprazole therapy: a report of two cases.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1995, Volume: 14, Issue:2

    Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto

1995
Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
    Pharmacology, 1994, Volume: 49, Issue:4

    Topics: Anti-Ulcer Agents; Bacterial Adhesion; Carcinoma; Cells, Cultured; Cimetidine; Duodenal Ulcer; Epith

1994
Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
    Archives of pediatrics & adolescent medicine, 1995, Volume: 149, Issue:3

    Topics: Abdominal Pain; Adolescent; Child; Chronic Disease; Drug Resistance; Esophagitis, Peptic; Gastritis;

1995
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
    Zeitschrift fur Gastroenterologie, 1994, Volume: 32, Issue:12

    Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter I

1994
Haemorrhagic gastritis in two patients treated with all-trans-retinoic acid in acute promyelocytic leukaemia.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:3

    Topics: Aged; Female; Gastritis; Gastrointestinal Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male;

1994
[Reversible thrombocytopenia due to digitoxin overdose].
    Deutsche medizinische Wochenschrift (1946), 1994, Dec-16, Volume: 119, Issue:50

    Topics: Aged; Digitoxin; Drug Overdose; Female; Gastritis; Gastroscopy; Heart Failure; Humans; Nausea; Omepr

1994
Helicobacter pylori: a fickle germ.
    Microbiology and immunology, 1994, Volume: 38, Issue:1

    Topics: Aerobiosis; Culture Media; False Negative Reactions; Gastritis; Helicobacter Infections; Helicobacte

1994
Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination

1994
Healing gastric MALT lymphomas by eradicating H pylori?
    Lancet (London, England), 1993, Sep-04, Volume: 342, Issue:8871

    Topics: Amoxicillin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymp

1993
Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects.
    Gastroenterology, 1994, Volume: 106, Issue:3

    Topics: Achlorhydria; Aged; Bacteria; Carbohydrates; Colony-Forming Units Assay; Fats; Feces; Female; Gastri

1994
[New development on the study of etiological pathology of gastritis, peptic ulcer and stomach cancers in relationship to Helicobacter pylori infection].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Sep-10, Volume: 82, Issue:9

    Topics: Antibodies, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male

1993
[The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis].
    Casopis lekaru ceskych, 1993, Jun-20, Volume: 132, Issue:14

    Topics: Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middl

1993
One-day therapy for treatment of Helicobacter pylori infection.
    Digestive diseases and sciences, 1993, Volume: 38, Issue:9

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy,

1993
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
    Gastroenterology, 1993, Volume: 104, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Division; Female; Gastrins; Gastritis; Helicobacter

1993
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm

1995
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
    Journal of clinical gastroenterology, 1995, Volume: 21, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; G

1995
Azithromycin for the cure of Helicobacter pylori infection.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:2

    Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combina

1996
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Carbamazepine; Clarithromycin; Drug Interactions; Drug The

1996
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:4

    Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; D

1996
Italian omeprazole triple therapy--a 1-week regimen.
    Scandinavian journal of gastroenterology. Supplement, 1996, Volume: 215

    Topics: Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter

1996
Inhibition of Helicobacter pylori by garlic extract (Allium sativum).
    FEMS immunology and medical microbiology, 1996, Volume: 13, Issue:4

    Topics: Anti-Bacterial Agents; Duodenal Ulcer; Enzyme Inhibitors; Garlic; Gastritis; Helicobacter Infections

1996
Helicobacter pylori and lanzoprazole.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Helicobacter

1996
Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole.
    Journal of gastroenterology, 1996, Volume: 31, Issue:1

    Topics: Adult; Duodenitis; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Intest

1996
Etiological involvement of Helicobacter pylori in "reflux" gastritis after gastrectomy.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:10

    Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Drug Therapy, Combination; Female; Gastric Muco

1996
[Association of chronic urticaria with Helicobacter pylori-induced antrum gastritis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:2

    Topics: Adult; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infe

1996
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:11

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim

1996
Atopic dermatitis successfully treated by eradication of Helicobacter pylori.
    Journal of gastroenterology, 1996, Volume: 31 Suppl 9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Blott

1996
Helicobacter pylori, gastric ulcer, and duodenal ulcer.
    The New England journal of medicine, 1996, Dec-12, Volume: 335, Issue:24

    Topics: Age of Onset; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omepr

1996
[Meta-analysis raises more questions, than it answers].
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:8

    Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal

1996
[Meta-analyses are hardly suitable for conclusively proving medical controversies].
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:8

    Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal

1996
[Meta-analysis should be regarded with extreme caution].
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:8

    Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal

1996
[Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Fortschritte der Medizin, 1996, Aug-20, Volume: 114, Issue:22-23

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administra

1996
Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis.
    Scandinavian journal of gastroenterology, 1996, Volume: 31, Issue:12

    Topics: Adult; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastrins; Gastritis; Gastroscopy; Helicobacter Inf

1996
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Revista espanola de enfermedades digestivas, 1996, Volume: 88, Issue:4

    Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug T

1996
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
    Leber, Magen, Darm, 1996, Volume: 26, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D

1996
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin

1997
Effective 2-wk therapy for Helicobacter pylori disease in children.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug T

1997
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
    Gastroenterology, 1997, Volume: 112, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Female; Gastric Mucosa; Gastrins; Gastritis; H

1997
[Helicobacter pylori eradication: finally clarity].
    Leber, Magen, Darm, 1996, Volume: 26, Issue:6

    Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter I

1996
Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Eruptions; Drug Therapy, Combination; Fe

1997
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarke

1997
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
    Medicina clinica, 1997, Apr-12, Volume: 108, Issue:14

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug

1997
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:6

    Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; D

1997
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
    Gut, 1997, Volume: 40, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug

1997
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
    Gastroenterology, 1997, Volume: 113, Issue:1

    Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gast

1997
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
    Journal of the National Cancer Institute, 1997, Sep-17, Volume: 89, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amoxicillin; Anti-Ulcer Agents; Disease-Free Su

1997
A prospective follow-up study of 5669 users of lansoprazole in daily practice.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen

1997
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
    Helicobacter, 1996, Volume: 1, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resist

1996
Cure of Helicobacter pylori: a hidden curse?
    The American journal of gastroenterology, 1997, Volume: 92, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esop

1997
Successful treatment of protein-losing lymphocytic gastritis with omeprazole.
    Journal of clinical gastroenterology, 1997, Volume: 25, Issue:4

    Topics: Aged; Female; Gastric Mucosa; Gastritis; Humans; Lymphocytes; Omeprazole

1997
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
    Gut, 1997, Volume: 41, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Epithelial C

1997
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; D

1998
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
    Journal of gastroenterology, 1998, Volume: 33, Issue:1

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therap

1998
Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia?
    Journal of gastroenterology and hepatology, 1997, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Female; Gastric Empty

1997
New, improved Helicobacter pylori eradication therapy in children.
    Journal of pediatric gastroenterology and nutrition, 1998, Volume: 26, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combinati

1998
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
    Gastroenterologia y hepatologia, 1998, Volume: 21 Suppl 1

    Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U

1998
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl B

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Dru

1998
The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease.
    Gerontology, 1998, Volume: 44, Issue:3

    Topics: Aged; Aging; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis;

1998
Effect of Helicobacter pylori infection on gastric juice pH.
    Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studi

1998
A study on the relation between proton pump inhibitor and gastric giardiasis.
    Journal of the Egyptian Society of Parasitology, 1998, Volume: 28, Issue:1

    Topics: Adult; Animals; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastritis; Giardia lamblia; Giardiasis; H

1998
Weekend therapy for the treatment of Helicobacter pylori infection.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:5

    Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Sc

1998
Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
    Journal of gastroenterology and hepatology, 1998, Volume: 13, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chem

1998
[Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study].
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:5

    Topics: Adult; Aged; Anti-Ulcer Agents; Biopsy; Chronic Disease; Esophagitis, Peptic; Female; Follow-Up Stud

1998
Omeprazole efficacy and Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:4

    Topics: Anti-Ulcer Agents; Dose-Response Relationship, Drug; Gastric Acid; Gastritis; Helicobacter Infection

1998
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Adult; Aged; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Muc

1998
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases;

1998
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
    Journal of pediatric gastroenterology and nutrition, 1998, Volume: 27, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; H

1998
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy.
    Journal of pediatric gastroenterology and nutrition, 1999, Volume: 28, Issue:3

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Granul

1999
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helic

1999
Does Helicobacter pylori affect the management of gastroesophageal reflux disease?
    The American journal of gastroenterology, 1999, Volume: 94, Issue:4

    Topics: Enzyme Inhibitors; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori;

1999
Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:4

    Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catalas

1999
Helicobacter heilmannii associated erosive gastritis.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:3

    Topics: Abietanes; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endoscopy, D

1999
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:8

    Topics: Adult; Aged; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multipl

1999
[Effect of Helicobacter pylori on gastric epithelial apoptosis].
    Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Apoptosis; Drug Therapy, Combination; Epithel

1997
Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Chronic Disease; Drug Th

1999
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
    Clinical pharmacology and therapeutics, 1999, Volume: 66, Issue:5

    Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bism

1999
Corpus-active gastritis with focal atrophy and parietal cell hyperplasia related to long-term use of omeprazole.
    Virchows Archiv : an international journal of pathology, 1999, Volume: 435, Issue:2

    Topics: Atrophy; Gastritis; Humans; Hyperplasia; Omeprazole; Parietal Cells, Gastric; Stomach; Time Factors

1999
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Fema

1999
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:1

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy,

2000
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Fe

2000
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
    Gastroenterology, 2000, Volume: 118, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Child; Drug Resist

2000
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:4

    Topics: Adult; Ammonia; Anti-Ulcer Agents; Female; Follow-Up Studies; Gastric Acidity Determination; Gastrit

2000
Histopathological features of gastritis before and after treatment for Helicobacter pylori.
    Croatian medical journal, 2000, Volume: 41, Issue:2

    Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infection

2000
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 31, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents;

2000
Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2000, Volume: 51, Issue:2

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Apoptosis; Endothelin-1; Gastric Mucosa; Gastritis; Helic

2000
Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease?
    European journal of gastroenterology & hepatology, 2000, Volume: 12 Suppl 1

    Topics: Esophagitis; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Human

2000
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.
    Gastroenterology, 2000, Volume: 119, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Ascorbic Acid; Female; Gastric Juice; Gastritis; Helicobacter Infections;

2000
Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
    Lancet (London, England), 2000, Aug-19, Volume: 356, Issue:9230

    Topics: Anti-Ulcer Agents; Barrett Esophagus; Drug Administration Schedule; Esophageal Neoplasms; Esophagiti

2000
Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2000, Volume: 51, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Aspartic Acid Endopeptidases; Endothelin-Converting Enzymes; Gastric Muc

2000
Helicobacter pylori infection in recurrent abdominal pain.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 31, Issue:4

    Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; C

2000
[Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole].
    Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:10

    Topics: Abdominal Pain; Anti-Ulcer Agents; Edema; Exudates and Transudates; Female; Gastritis; Humans; Lymph

2000
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.
    Acta paediatrica (Oslo, Norway : 1992), 2000, Volume: 89, Issue:11

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Bacterial

2000
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Enterochromaffin-like Cells; Enzyme Inhibitors; Fema

2001
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
    Diabetes research and clinical practice, 2001, Volume: 52, Issue:1

    Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, T

2001
Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Diseas

2001
Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.
    Helicobacter, 2001, Volume: 6, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cell Division; Clarithromycin; Dose-Respons

2001
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
    Gastrointestinal endoscopy, 2001, Volume: 54, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Comm

2001
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
    The American journal of medicine, 2001, Volume: 111, Issue:2

    Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Heli

2001
Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
    Zeitschrift fur Gastroenterologie, 2001, Volume: 39, Issue:7

    Topics: Adult; Aged; Amoxicillin; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy,

2001
[The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis].
    Klinicheskaia meditsina, 2001, Volume: 79, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Chronic Disease

2001
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru

2001
Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
    European journal of gastroenterology & hepatology, 2001, Volume: 13 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chronic Disease; Dyspepsia; Gastritis; Helicobacter Infecti

2001
[Gastroduodenitis and ulcers--statistical study for 1998].
    Vutreshni bolesti, 2000, Volume: 32, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther

2000
Fundic gland polyps are not induced by proton pump inhibitor therapy.
    American journal of clinical pathology, 2001, Volume: 116, Issue:5

    Topics: Enzyme Inhibitors; Female; Gastric Fundus; Gastritis; Helicobacter Infections; Helicobacter pylori;

2001
Hypergastrinemia in response to gastric inflammation suppresses somatostatin.
    American journal of physiology. Gastrointestinal and liver physiology, 2002, Volume: 282, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Fundus; Gastric Mucosa; Gastrins; Gastriti

2002
Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice.
    Gastroenterology, 2002, Volume: 122, Issue:1

    Topics: Achlorhydria; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; B-Lymphocytes; Bacteriological Tech

2002
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
    Medizinische Klinik (Munich, Germany : 1983), 2002, Jan-15, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany;

2002
Helicobacter pylori eradication: do we have another ace up our sleeve?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Infective Agents; Be

2001
Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:11

    Topics: Acids; Anti-Ulcer Agents; Ascorbic Acid; Drug Therapy, Combination; Female; Gastritis; Helicobacter

2001
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
    Pathology international, 2002, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clari

2002
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; D

2002
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
    Quintessence international (Berlin, Germany : 1985), 2001, Volume: 32, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarith

2001
Omeprazole therapy for Helicobacter pylori infection.
    Scandinavian journal of gastroenterology, 1992, Volume: 27, Issue:12

    Topics: Adolescent; Adult; Child; DNA Fingerprinting; Duodenal Ulcer; Female; Gastritis; Helicobacter Infect

1992
In vitro activity of antifungal azoles against Helicobacter pylori.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:3

    Topics: Antifungal Agents; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Test

1992
[Peptic ulcer and drug therapy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Jan-10, Volume: 80, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Ga

1991
Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration.
    Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:9

    Topics: Adult; Eosinophilia; Female; Gastritis; Gastroscopy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ra

1991
Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis.
    Alimentary pharmacology & therapeutics, 1991, Volume: 5, Issue:4

    Topics: Adult; Aged; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle

1991
Antral Helicobacter pylori-like organisms in different states of gastric acid secretion.
    Digestion, 1991, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastric Acid; Gastritis; Helic

1991
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
    American journal of veterinary research, 1991, Volume: 52, Issue:5

    Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Dog Diseases; Dogs; Double-Blind Method; Gastrit

1991
[Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori].
    Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Campylobacter Infections; Ciprofloxacin; Drug

1991
Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine.
    Digestion, 1991, Volume: 48, Issue:3

    Topics: Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Humans; Hydrogen-Ion Concentration;

1991
[Current perspectives in ulcer disease].
    Therapeutische Umschau. Revue therapeutique, 1990, Volume: 47, Issue:8

    Topics: Anti-Bacterial Agents; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Huma

1990
Elimination of Helicobacter pylori under treatment with omeprazole.
    Zeitschrift fur Gastroenterologie, 1990, Volume: 28, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections;

1990
[A case of protein-losing lymphocytic gastritis treated by omeprazole].
    Gastroenterologie clinique et biologique, 1990, Volume: 14, Issue:4

    Topics: Adult; Blood Proteins; Female; Gastric Mucosa; Gastritis; Humans; Lymphocytes; Omeprazole

1990
Acute haemorrhagic gastritis controlled by omeprazole.
    Lancet (London, England), 1989, Apr-08, Volume: 1, Issue:8641

    Topics: Acute Disease; Gastritis; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole

1989
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer.
    Lancet (London, England), 1989, Dec-09, Volume: 2, Issue:8676

    Topics: Campylobacter; Campylobacter Infections; Duodenal Ulcer; Gastritis; Humans; Omeprazole

1989
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
    The Medical journal of Australia, 1985, Feb-04, Volume: 142 Spec No

    Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Critical Care; Gastri

1985